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Abstract
Co-crystals are multi-component, single phase materials in which the co-
crystal formers exist in an uncharged state. This interaction between com-
ponents occurs without aﬀecting the intra-molecular covalent bonding of
the involved components or altering their chemical integrity. This class of
materials has recently gained the interest in the pharmaceutical industry
for modifying the physicochemical properties of some active pharmaceu-
tical ingredients (APIs) such as solubility, hygroscopicity, and mechanical
properties.
However like all multi-component systems, there are some analytical
challenges associated with using traditional quality control (QC) tools that
involve sample preparation steps prior to the analysis. This can sometimes
have an impact on the physical state of such systems and therefore aﬀect
the outcomes of analysis correlated with the actual materials.
Flurbiprofen (FBP) and nicotinamide (NCT) in this work were se-
lected to form a model co-crystal system. FBP falls in the carboxylated
group of non steroidal anti-inﬂammatory drugs (NSAIDs), used herein as
an API. It belongs to class II of the Biopharmaceutics Classiﬁcation Sys-
tem (BCS), therefore its low aqueous solubility and dissolution rate aﬀect
its bioavailability. NCT is a vitamin B3 derivative and generally regarded
as safe (GRAS) substance. It is used as co-crystallising agent due to its
solubility enhancing property.
FBP-NCT co-crystal system was previously studied by Berry et al.,
where a FBP-NCT co-crystal was prepared using Koﬂer method and screened
VII
VIII
by means of the hot-stage microscopy (HSM). FBP-NCT co-crystal was re-
cently prepared via rapid evaporation from ethanol solution, and screened
for its physicochemical and mechanical properties by Shing et al. who found
an improvement in such properties compared to the pure API (FBP).
There is a wide range of methods for preparing co-crystals, of which
methodologies with minimal environment impact were mainly adopted in
this work i.e., Koﬂer fusion and co-grinding methods. Within the Koﬂer
fusion method, it was feasible to identify and screen simultaneously parent
components as well as the emerging material at room temperature (RT)
by means of confocal Raman microscopy. Detailed information from Ra-
man mapping on the investigated phases were achieved using statistical
analysis. The analysis resulted in a reﬁnement regarding the traditional
assumption about the binary phase diagram. It also revealed the presence
of two forms of FBP-NCT co-crystals which were consequently explored by
coupling thermal analysis with Raman spectroscopy and X-ray diﬀraction.
Using co-grinding preparation, FBP-NCT co-crystals were prepared
on a large scale; enough for solid dosage formulation. Subsequent crystalli-
sation of the resulting compound using a solution method generated single
crystals suitable for x-ray crystal structure determination.
Moreover in this work, a solid-state dosage form of FBP-NCT co-
crystal was prepared for the ﬁrst time, then investigated using transmission
Raman spectroscopy. The investigation included the presence of drug and
excipient, and their composition in tablets. This procedure can be consid-
ered as a platform for studying the QC of drug preparation, using a reliable,
non-destructive, non-invasive, and very rapid analytical tool. Such type of
study complied well with the food and drug administrative (FDA) outlines
on employing process analytical technology (PAT) protocol for analysing
and controlling pharmaceutical manufacturing processes.
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CHAPTER 1
General Introduction
1.1 Pharmaceutical Drug Development
World research and development (R&D) expenditure reached over $120 bil-
lion annually in the areas of pharmaceutical and biotechnology, and general
industries1. Pharmaceutical research-based investment has vastly increased
compared to other innovation (ﬁg 1.1 a). It has proved to be the lead
advancing sector in global healthcare since 19502. This is in part due to
the interest in using the state-of-art technology to understand the mecha-
nism of complex disease and most importantly ﬁnd the right medication.
Developing a new medicine is very challenging involving long and complex
procedures. Part of this challenge relates to the regulatory authorities only
approving few drugs out of the many candidates entered into clinical trials
(ﬁg 1.1 b). Drug development hence takes a very long time (10 to 15 years)
and is an expensive process (ﬁg 1.1 b, c). R&D investments increased by
$35 billion in 5 year period since 1995 as reported by the Pharmaceutical
Research and Manufacturers of America (PhRMA)3 (ﬁg 1.1 c). According
to PharmSource®, the global R&D investment share in the pharmaceutical
industry is divided almost equally on preparation methods, characterisa-
tion, and drug formulation (ﬁg 1.1 d)46. Despite such huge investment,
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the productivity of R&D has fallen in the last 10 years7,8. There has been
a decrease in the number of new drug approvals of priority or standard
need (ﬁg 1.1 c), and this has led to ﬁling more applications to patent new
commercial products of comparable characteristics to existing products of
expired patents911.
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Figure 1.1: R&D expenditures and drug approval process. The industrial world
investment on R&D (2008-2009) is shown in (a) the plot was generated after
the international federation of pharmaceutical manufacturers & associations (IF-
PMA)1. Being more interested in the R&D process within the pharmaceutical
ﬁeld, the process drug development is shown in (b) "as reported by PhRMA
(Pharmaceutical Industry 2011 proﬁle, p.12)"1. The number of new drug ap-
provals and R&D expenditures in US$ billions over the last 11 years are shown
in (c) "as reported by FDA and PhRMA (1990 - 2011)11". The global spending
(US $ millions) on analytical development & testing processes of drug substance
is in (d), the plot was generated after PharmSource® report4.
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1.2 Molecular Properties of Drug Substances
While the focus in research units and organisations or even the pharmaceuti-
cal companies is to introduce new molecular entities (NMEs) with improved
properties, other options can be taken based on the existing products such as
using alternative solid-state forms. Pharmaceutical substances range from
a single component (crystalline or amorphous) to multi-component systems
such as hydrates/solvates, clathrates, salts, and co-crystals.
The reason for having such variation in pharmaceutical solid-state
materials is due to drug chemistry and the need to introduce medications
with desired physicochemical properties. Drug molecules may contain dif-
ferent functionalities which with the surrounding environment contribute
to the ionization degree of molecule. The ion class state of the APIs varies
from a non-ionisable (neutral) to an ionisable (acidic or basic) state. This
compound status plays a key role in the ADME biopharmaceutical proper-
ties (absorption, distribution, metabolism, and excretion) of the drug. This
is because the degree of ionisation (acidity/basicity, pKa/b) can aﬀect the
solubility (LogS), drug distribution (LogD), and lipophilicity (LogP) proﬁle
of the compound1214.
The eﬀect of ion class compounds on the molecular properties of
10,270 drugs, which belong to 12 large pharmaceutical companies∗ (ﬁg 1.2
a), was studied by Lesson et al.14. The study showed that the majority
of substances belong to basic and neutral classes (ﬁg 1.2 b) and that
bases have a higher lipophilicity proﬁle compared to acids and neutrals14.
However, the increase level of lipophilicity in ion class compounds (LogP >
3) holds a risk of producing drugs of a high toxicity1517. Regarding drug
∗AstraZeneca (1337 compounds), GlaxoSmithKline (1402 compounds), Merck (1519
compounds), Pﬁzer (1222 compounds), Abbott (392 compounds), Bristol-Myers Squibb
(689 compounds), Janssen (581 compounds), Lilly (406 compounds), Novartis (615 com-
pounds), Roche (784 compounds), Sanoﬁ-Aventis (856 compounds), and Wyeth (467
compounds).
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distribution, the cLogD value decreases among ion class compounds in the
following order neutrals > bases > acids, due to their increased plasma
protein binding1821. Hence, neutral pharmaceuticals can be advantageous
over ionic substances in terms of toxicity and eﬃcacy. However, ionised
compounds (acids or bases) are generally more soluble than neutrals (non-
ionised). The poor solubility of neutral molecules can be improved when
molecules are complexed with other solubility enhancing agents under a
condition of choosing the right complementary agents, which is the case
of designing multi-component systems. Multi-component systems not only
oﬀer the chance of improving the solubility but they can also modify the
mechanochemical and physicochemical properties of substances such as the
compressibility, hygroscopicity, and stability2232.
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Figure 1.2: Ion class fraction of 10,270 oral drug compounds from of 12 phar-
maceutical companies (a). The ionic composition of such compounds is shown in
(b). The plot was generated after Lesson et al.14.
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1.3 Solid-State Materials
The physicochemical properties of substances is aﬀected by the crystalline
diversity of materials. Richard P. Feynman (a theoretical physicist) did
once anticipate a change in the properties of substances if their structures
have been rearranged∗, "What could we do with layered structures with just
the right layers? What would the properties of materials be if we could really
arrange the atoms the way we want them? ..... we will get an enormously
greater range of possible properties that substances can have, and of diﬀerent
things that we can do." 33.
The design of solid-state forms varies according to the requirement
of usages such as in the agriculture, nutrition, pharmaceutical, chemical, or
material science (applies physics, and forensic engineering) ﬁeld34,35. Solid-
state materials range from a single component with diﬀerent polymorphic
forms (ﬁg 1.3) to molecular complexes (ﬁg 1.4, 1.5), depending on the
number of components in the crystal lattice. In multi-component systems,
the second component can be water, solvent, ion, or a co-crystal former.
If there is a proper periodic arrangement between molecules (crystalline),
then the resulting compounds are hydrates, solvates, clathrates, salts, or co-
crystals (ﬁg 1.4, 1.5). However, if there is a randomness in the molecular
arrangements then amorphous forms (non-crystalline) result, a phenomenon
not only observed in single components but also in molecular complexes.
Molecules which adopt crystalline structure, whether single or multi-
component systems, can sometimes adopt diﬀerent conformation and pack-
ing forms, and this leads to so called polymorphism. Polymorphism and
allotropism are related, the ﬁrst term is used to describe the diversity in
the structure of molecular compounds while the second one is related to the
∗Feynman's talk was given on the 29th December 1959 at the California Institute of
Technology (Caltech) in the annual meeting of the American Physical Society33.
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Figure 1.3: Schematic of single component polymorph. The ﬁgure is very com-
parable to wall brick whereas the brick units can be arranged in diﬀerent forms.
The more the block units are interlinked, the stronger the building becomes.
The polymorphism phenomena resulted to materials with diﬀerent physicochem-
ical properties such as the diﬀerences between carbon allotropes diamond and
graphite.
diversity in the structure of elements. An example for allotropism is carbon
(C). Carbon has few allotropes such as diamond and graphite whereas the
arrangement of the atoms is diﬀerent between diﬀerent structures, and this
accordingly leads to diﬀerences in the properties. Equally is the case of
organic molecules which can exhibit diﬀerences in the packing or the con-
formational arrangements within polymorphic molecules and a change in
properties can result.36.
Polymorphism was reported for the ﬁrst time by F. Wöhler and
J. Liebig in 1832, who discovered polymorphism in benzamide37. Later
on, F. Wöhler reported the ﬁrst molecular complex quinhydrone (quinone-
hydroquinone co-crystal) in 184438. In 1931, J.S. Buck and W. Ide reported
the formation of additional compounds during bezoin reaction. These com-
pounds contained equimolar amounts of two diﬀerent benzoin derivatives39.
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Figure 1.4: Schematic of molecular complexes. It shows in (a) the formation of
salts in the presence of ions, while in (b) it resulted in solvates/hydrates in the
presence of solvents/water.
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Figure 1.5: Schematic of co-crystal polymorphism. It shows the formation of
co-crystal between one substance and a co-former in various packing and conﬁg-
uration manner between two ratios of linkage.
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The formation of mixed crystals was found to occur by accident until
the structures of organic molecules were rationally studied by S. J. Anderson
in 193740 and then by Etter et al. in 198341 and A. I. Kitaigorodsky in
198442. The latter published a book entitled "Mixed Crystals in Solid-
State Sciences" describing the principle of close packing and the structure of
solid-state materials42. Researchers have found that the formation process
of molecular complexes does not occur randomly, but it rather requires
studying the property of the crystal structural relationships and the possible
packaging arrangement43.
1.3.1 Crystal and Supramolecular Engineering
The concept of crystal engineering was introduced ﬁrst by R. Pepinsky in
195544,45. It has matured into preparing new compounds (molecular com-
plexes) with enhanced physicochemical properties46. The main strategies
in molecular complexes design focus on the structural compatibility and the
energetic interactions between components47.
The design of multi-component complexes follows the same protocols
as crystal engineering, in terms of studying the crystal structural property
relationships (the intermolecular interaction) and the possible packaging
arrangements (the spatial arrangements), obtained through the Cambridge
Structural Database (CSD)∗ 48.
According to Corey†, supramolecules are assembled from synthons
which are basically formed via the intermolecular interaction between com-
plementary functional groups of molecules43. This description is simpliﬁed
∗ CSD is a database repository of small molecules (organic and meta-organic com-
pounds). It enables to visualise the chemical and crystallographic analysis of materials,
and the determination of the three dimension (3D) structure calculated based on the
diﬀraction of neutrons or x-rays.
†Supramolecular synthons are structural units within supermolecules which can be
formed and/or assembled by known or conceivable synthetic operations involving inter-
molecular interactions 43.
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Figure 1.6: From molecular to supramolecular chemistry. It represents the self
assembly of molecules into crystals, then supramolecular synthons.
in ﬁg 1.6 which displays the relationship between molecular and supramolec-
ular chemistry. It shows that the crystalline structure is built up from
molecules of complementary functional groups which intermolecularly in-
teract to form a supramolecular synthon. The latter stands as the building
blocks of supermolecules.
As mentioned previously, supramolecular synthons are constructed
as a result of intermolecular interactions. Such interactions play an im-
portant role in supramolecular synthesis since they contribute in shaping
molecules, deﬁning their size and close packing. There are a number of
such interactions, the most important type in the synthesis of molecular
complexes is hydrogen bonds43,48,49.
Bridging hydrogen bonds occurs between two moieties, usually com-
plementary functional groups such as (H) connected to a donor and (O) as
an acceptor (ﬁg 1.7). The most important aspects in hydrogen bonds are
the length between acceptor...donor (i.e., O...H=donor) and acceptor...H
(i.e., O...H), and the hydrogen bond angles ϕ (atom=acceptor...H) and θ
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(acceptor...H=donor). It also requires a coordination between the angle
θ (acceptor...H=donor) and the length of (acceptor...donor) bond48. The
ideal distance between acceptor and donor falls within a range of 1.60 to
2.00 Å for bonds such as O...HN and O...HO. In addition, the preferable
values for θ are around 150-160° and around 120-130° for ϕ43.
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Figure 1.7: Hydrogen bond interaction between two complementary moieties.
It shows the donor and the acceptor moieties, the complementary atoms (O, H),
angle (θ, ϕ) and the (arrows) to indicate to the distance between (O, N) and (O,
H).
Since the intermolecular interactions (hydrogen bonds type) are con-
sidered weak individually, the robustness of synthon, and spatial arrange-
ment and conformation packaging become essential in the supermolecular
design area. For instance, a carboxylic functionality is a common group
that has been widely studied in crystal engineering. This group can form
either supramolecular homosynthon or supramolecular heterosynthon, de-
pending on the other complementary moiety. Interaction between similar
functional groups yields homosynthon supramolecular structure but this is
not energetically favourable. Alternatively, the interaction between diﬀerent
groups is more preferable. It produces supramolecular heterosynthon such
as between carboxylic acid and amide, or carboxylic acid and pyridine∗ 34.
∗In fact, carboxylic acid-pyridine interaction is more preferable than carboxylic acid-
amide one 34.
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Hence, it is not preferable from the crystal design point of view to
have interactions between similar groups i.e., amide-amide or carboxylic-
carboxylic, when compared to supramolecular heterosynthon such as car-
boxylic acid-pyridine, carboxylic acid-amide, alcohol-amine and alcohol-
pyridine (ﬁg 1.8). Brieﬂy, molecular complexes are likely to be thermo-
dynamically favoured when two diﬀerent components with complementary
functional groups are capable of producing hydrogen bonds energetically
stronger than those between molecules of each component.
  
Or Carboxylic-Amide
Flurbiprofen Nicotinamide
N-pyridine-Carboxylic Interaction
90%
47%
Flurbiprofen Nicotinamide
The probability of Interaction according to CSD
FBP-NCT Supramolecular Synthon
Figure 1.8: Probability of interactions between complexes according to CSD.
Molecular complex formation is governed by chemical and geomet-
rical factors. Such phenomena can be illustrated through intermolecular
interactions including, the non-covalent bonds hydrogen pattern and the
recognition of crystal packing, an observation very comparable to enzyme-
substrate interactions or the lock and key principle ﬁg 1.6. However, for
attenuating other inﬂuencing factors such as competition, cooperation and
balance between intermolecular forces design, it is advisable to adopt strate-
gies set by M. Etter and co-workers for co-crystal design. These rules reﬂect
kinds of intermolecular association that are energetically favorable 49:
 Good proton donors and acceptors are utilised in hydrogen bonds and
only the best proton donors and acceptors remain.
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 In the presence of the other functional groups and under the impact
of various packing patterns, each functional group should retain its
preferred interaction pattern.
Such rules are useful in avoiding many obstacles in co-crystal synthesis. For
instance, the interference of competitive intra-molecular hydrogen bonds
could be overcome by selecting other component as a guest that has the
ability to conduct stronger hydrogen bond with the hosted molecule.
1.3.2 Pharmaceutical Co-crystals Background
Crystal engineering has addressed approaches to developing a new class
of compounds (co-crystal) under a broad group of multi-component crystal
structures (solvates, hydrates, clathrates, inclusion crystals)50. There is still
a debate over ﬁnding a comprehensive deﬁnition for co-crystals32,34,45,5154.
One widely used deﬁnition is that co-crystals are multi-component crystals
or molecular complexes, in which all molecules are solid at ambient condi-
tions48. The molecules of co-crystal exist in diﬀerent stoichiometric amounts
through non-covalent bonds and are packed in a well deﬁned order. The
interaction in co-crystal compounds (hydrogen bonds) occur between com-
plementary supramolecular synthons without breaking covalent bonds, or
altering the chemical integrity of each molecule48,55. Hydrogen bonds are
generally formed between active pharmaceutical ingredients and co-crystal
agents. The latter should be non-toxic and pharmaceutically acceptable.
There is a library for co-crystal agents56 and it includes pharmaceutical
excipients and compounds which are generally recognized as safe (GRAS)
such as benzoic, succinic, fumaric acids, and nicotinamide34.
The main diﬀerence between solvates and co-crystals is the physical
state of parent pure components at room temperature. If one component is
a liquid (water or solvent), then crystals are assigned as hydrate or solvates;
but if they are solids then the resulting crystals are co-crystals. Alterna-
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tively, the distinction between co-crystal and salts is based on the diﬀerence
in the pKa between base and acid (△pKa). If it is greater than 3.75 then
a complete proton transfer is expected ending with the formation of salts
likely. However, if the proton transfer is absent then a neutral compound
(co-crystal) will be formed. There are some cases where the pKa of both
components is very similar, in this case the environment determines the
extent of proton transfer54,57,58.
Like other crystalline forms of the APIs, co-crystals can be designed
by synthon strategies but that does not mean they are always formed
as predicted. Therefore, pharmaceutical co-crystals can be considered as
patentable inventions. For instance, S. Fox invented nicotinamideascorbic
acid co-crystal system in 1947, vitamin C (ascorbic acid) in this compound
will retain its stability and hence its potency will not be aﬀected by sur-
rounding environment59. H. Zellner invented a new co-crystal of α-naphthyl
acetic acid with purine (caﬀeine or theophylline). The whole compound was
found to be more soluble than individual purine substances, plus it has an
antiphlogistic eﬀect. This invention was accordingly disclosed in a US patent
as an anti-Inﬂammatory compound in 196160. S. Childs as well in 2008 dis-
closed a US patent to novel co-crystals and a protocol for co-crystallisation
methodology61. He prepared three co-crystals of ﬂuoxetine HCl with three
diﬀerent acids; succinic acid, fumaric acid, and benzioc acid. Based upon
this he expanded the protocol to be applicable on the free base of the APIs,
whereas the API should be prepared in salt form, such as NaCl, then co-
crystallised with carboxylic acid for instance61. Therefore, co-crystals have
an important place for further development in the pharmaceutical indus-
try if a found compound exhibits improved physicochemical properties and
clinical advantages over individual API.
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1.3.3 Co-crystal Role in Drug Development
All solid-state state materials are important to the pharmaceutical industry,
both single-component crystals and multi-component crystals (hydrates,
solvates, salts and co-crystals) are used to modify the physicochemical prop-
erties of the drugs. There are however, some advantages of speciﬁc solid-
state forms over others. Hydrates/solvates, for instance, are less likely to be
useful when compared to salts and co-crystal. This is because the number
of acceptable solvents are small compared to counter ions and co-crystal
agents. The stability of hydrates/solvates is also an issue, as such com-
pounds undergo dehydration/desolvation in the solid dosage forms under
uncontrolled storage conditions. The loss of water or solvent might lead to
unfavoured solid-state forms62. In contrast, salts and co-crystal are more
stable as complexes with counter ions and co-crystal formers.∗
The formation of salts is more rational compared to the formation
of other molecular complexes (Hydrates/solvates), however it is mainly tar-
geted to ionised molecules (basic or acidic). As a result, unionised APIs
components which comprised nearly 40% of formulated drugs lack the abil-
ity of salts formation. Thus, the class of co-crystal compounds might oﬀer
the opportunity to modify the physical properties of APIs without alter-
ing their chemical identities via complexes formation with co-crystallising
agents of complementary functional groups32,65.
Pharmaceutical co-crystal synthesis has been implemented to im-
prove the physiochemical properties (solubility, stability, and bioavailabil-
ity) of some of APIs47,6670. For instance, the stability of caﬀeine-dicarboxylic
acid co-crystal in diﬀerent relative humidity (RH) conditions was investi-
gated and it has been found that this co-crystal exhibits better stability
in various percentages of RH when compared to anhydrous caﬀeine24. The
∗ However, this does not exclude the chance of forming hydrates of salts or co-crystal
under changed RH63,64.
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humidity contributes in the transformation of one speciﬁc crystal form to
another24. Equally are polymorphs which may undergo a conversion to
more stable crystalline form during storage and manufacturing process. For
example, a change in carbamazepine (CBZ) form III has been noticed be-
tween batches71; form III was used to enhance the oral bioavailability of
CBZ71.
Hence, co-crystal engineering is driven by the need to improve the
physiochemical properties of pharmaceutical active ingredient. For instance,
Indomethacin (IND) was co-crystallised with saccharine (SAC) in order to
improve drug solubility26. It was found that the IND=SAC co-crystal dis-
played faster dissolution rate than IND (γ-form). Caﬀeine=dicarboxylic
acid co-crystal is another example24. The stability of this co-crystal was
investigated at various RHs24. It has been found that this preparation
exhibited better stability compared to anhydrous caﬀeine. Moreover, the
pharmacokinetics of CBZ were screened when co-crystallised with SAC in
dog models71. CBZ=SAC co-crystal exhibited a higher Cmax (Maximum
Plasma Concentrations) and Tmax (Time to Maximum Plasma Concentra-
tion) compared to marketed CBZ (Tegretol®). In addition, it displayed an
increase in the dissolution properties in regard to amorphous CBZ.
1.4 PAT & QC Analytical Drug Tools
As mentioned at the beginning of this chapter a lot of eﬀort, time, and
investment are devoted to develop NMEs or novel crystal forms which can
be readily released into the market. Accordingly and because most of drugs
are in a high demand, medicines becomes very expensive. As a result, an
increasing number of counterfeit medicines have been reported72. Therefore,
the regulatory authorities such as the FDA has strengthened the rules on
drugs in development processes and product characterisation to minimise
as much as possible the phenomenon of counterfeiting medicines.
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There is a wide range of tools used for drug analysis. Traditional
methods employ mostly chromatographies technique (i.e., high-performance
liquid, gas, or thin-layer chromatography), and spectroscopies (i.e., Ultra-
violetvisible (UV-Vis) and ﬂuorescence spectroscopies). Employing such
techniques requires sample preparation, including for instance dissolution,
and calibration for each individual component within every sample. How-
ever, there are some challenging systems for which the traditional QC meth-
ods of screening and characterisation is not ideal such as some solid-state
forms (polymorphs, salts, co-crystals and amorphous materials), and fake
dosage forms (counterfeiting medicines).
Such systems are not amenable to be analysed using techniques which
involve some sample preparation steps that aﬀect the physical status of the
drug. Most of the time the information needed in screening medications is
not only about the chemistry but also about the physicochemical status of
formulated APIs. For example, does the formulation contain pure APIs or
it is accompanied by diﬀerent state form i.e., diﬀerent polymorphs or even
a co-crystal accidently formed between the API and one of the excipients.
In another word, the intermolecular or intra-molecular information has to
be conﬁrmed during the development and the formulation processes.
Finding robust techniques for drug analysis during drug development
and manufacturing process has become an essential requirement within
the pharmaceutical industry73. The emphasis is to ﬁnd a reliable, non-
destructive, non-invasive, and rapid analytical tool. All of which underlay
within the protocols of employing a real-time QC tools to design and anal-
yse manufacturing and production processes or so called PAT the process
analytical technology74,75.
Most of the vibrational spectroscopic techniques such as infra-red
(IR)7679, terahertz and Raman spectroscopy can meet such criteria. They
are considered as non-destructive tools of analysis mostly utilised with-
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out major sample preparations. Within the pharmaceutical area, vibra-
tional spectroscopic techniques are used for screening the physical and
physicochemical-chemical properties of components. Some of these ana-
lytical tools are more advantageous over others and this is dependant on
the type of information required to be achieved.
For instance, near infra-red (NIR) spectroscopic analysis is widely
used for quality control purposes in the pharmaceutical ﬁeld as it provides
a speciﬁc ﬁngerprint identiﬁcation for each molecule80. Mid-IR is used to
probe the structural information so it is well suited to probe the intra-
molecular interactions. Finally, terahertz spectroscopy is used to probe
the intermolecular interactions and thus it is good for characterising solid-
state forms of molecules such as polymorphs and multi-component systems.
Terahertz spectroscopy can be used along with IR to provide a complete
chemical information encompassing both intermolcular (phonon) and intra-
molecular regions81. Alternatively, such rich information is obtainable using
diﬀerent data acquisition instruments.
For instance using Raman spectroscopy such details can be simul-
taneously achieved from a full spectral range covering both phonon and
molecular regions (30-2000 cm-1). Raman spectroscopy is relatively easy to
handle 82 and can be used in reﬂective and transmission modes. Raman is
mainly used in a backscattering mode and in this way provides real chemical
information about drug identiﬁcation, distribution, and stability from the
surface and near surface regions of a sample. In transmission mode, data
can be gathered from the bulk of a sample8385.
1.5 Flurbiprofen:Nicotinamide Case Study
Flurbiprofen is a member of the carboxylated group non steroidal anti-
inﬂammatory drugs. It belongs to class II of the Biopharmaceutics Classiﬁ-
cation System, therefore has a limited bioavailability due to its low aqueous
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solubility and dissolution rate86. It is also known for its polymorphic be-
haviour87. It has been studied with nicotinamide in solid dispersion form
in 2005 by Varma et al., who showed that the dissolution and the solubility
of Flurbiprofen-Nicotinamide solid dispersions were improved compared to
those of Flurbiprofen88. Nicotinamide is listed as a generally regarded as
safe substance and suitable for human use56. It serves as an enhancing sol-
ubility agent, for instance it was also found to hydrotropically increase the
solubility of ibuprofen89 and riboﬂavin90.
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Figure 1.9: The chemical structure of the API (ﬂurbiprofen) in (a), and the co-
crystallising agent (nicotinamide) in (b). It shows the complementary functional
groups (COOH) in (a) and (CONH2, N-pyridine) in (b).
In 2008, both FBP and NCT have been explored in a diﬀerent solid-
state system, they were studied in a Koﬂer melt∗ by Berry et al.91 and
Blagden et al.92. Koﬂer melt preparation has been adopted to overcome the
eﬀect on steric hindrance of FBP structure when co-crystallised with small
molecules such as nicotinamide91. Flurbiprofen contains a carboxylic acid in
its structure (ﬁg 1.9 a), which serves as a complementary functional group
to nicotinamide amide group (ﬁg 1.9 b), and so can aid in the hydrogen
bond interactions between FBP and NCT. Following such studies, in 2012,
∗Koﬂer melt is a thermal technique based on a fusion between two components. Com-
ponents are sandwiched between a side and coverslip which allows to form by melting
a composition gradient and subsequently potential molecular complexes at the zone of
melting.
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the dissolution rate, moisture sorption, and the mechanical properties of
FBP-NCT co-crystal, prepared from a rapid evaporation of ethanol solution
of 1:1, FBP:NCT mixture, have been found to be improved over the pure
FBP86. Hence, FBP-NCT co-crystal can be considered as a model co-crystal
system to be explored starting from preparation to solid formulation using
diﬀerent methodologies.
1.6 Aims and Objectives
In this work, co-crystal was chosen as a solid-state system to be explored
motivated by the recent interest of the pharmaceutical industry in multi-
component systems. Co-crystals have became an increasingly attractive
option for tailoring the physiochemical properties of drug substances. The
study employed FBP-NCT co-crystal as a model system based on previous
work done by Berry et al.91 and Blagden et al.92 using Koﬂer melt, and
recently supported by Shing et al.86.
During presented work, FBP-NCT co-crystal were prepared using en-
vironmentally friendly methodologies. The resulting compounds screened
by means of a rapid and reliable analytical tool. The methods of co-
crystallisation compromised not only the Koﬂer fusion method but also
mechanochemical technique (liquid assisting grinding). The resulting com-
pound was subsequently formulated in tablets as a solid dosage formulation.
Such preparation methodologies and the resulting materials were evaluated
for their eﬀectiveness using various tools.
Traditional Screening Tools
 Diﬀerential Scanning Calorimetry (DSC) to identify the thermal be-
haviour of starting materials and resulting compound,
 HSM to optically clarify the thermal behaviour of studies materials,
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 Single X-ray Diﬀraction (SXD) to identify the crystallographic chem-
ical structure FBP-NCT co-crystal,
 X-Ray Powder Diﬀraction (XRPD) to investigate the structural be-
haviour of formed compounds. It was also used coupled with environ-
ment heating system.
Raman As A State-of-art Screening Tool
 Raman microscopy which was coupled with variable heating control
system, to identify the chemical characteristics, and map the distri-
bution of drug ingredients (both the chemistry and the composition)
within sample preparations.
Therefore, the aim of this research project was to assemble a model co-
crystal system using various methodologies and investigate the use of state of
the art Raman and X-ray powder diﬀraction as the main analytical tools to
study co-crystal preparations and co-crystal dosage formulation (tablets).
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Preparation Methods and
Screening Techniques
2.1 Pharmaceutical Co-crystal Preparations
There is a range of methodologies for preparing pharmaceutical co-crystals.
They fall under three main mechanisms; the dissolution, mechano-chemical
grinding, and Koﬂer fusion contact method.
2.1.1 Growth from Solution
Co-crystals can potentially be achieved by slow evaporation of a solution
containing stoichiometric amounts of components93. Solution evaporation
leads to supersaturation phase which resulted in the precipitation of either
new compounds or a mixture of components. Crystallisation from solu-
tion is traditionally used in the pharmaceutical industry for isolating single
component crystals. This technique is exploited to generate pharmaceutical
co-crystals from supersaturated solutions. This process is triggered by dis-
solving stoichiometric amounts from the API and the co-crystallising agent
in a suitable solvent (ﬁg 2.1).
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Figure 2.1: Co-crystal preparation from a solution.
However there are some considerations about this method: The ﬁrst
one is regarding the solubility of components in the chosen solvent. Both
components have to exhibit similar solubility in the selected solvent (ﬁg
2.2 a), otherwise the least soluble material would precipitate before the
completion of interaction. The mismatching in component solubility leads
to a mixture of co-crystals and single component phases (ﬁg 2.2 b)92. The
other foible about this methodology is the existence of further layering of
solvent as a ternary phase with the resulting compound92,94. Such impact
can be leveled up by choosing components with similar solubilities in the
selected solution, or dissolving components in a mixture of solvents94.
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Figure 2.2: Ternary phase diagram of two components dissolved in a solution.
(a) phase diagram of two components (cp1) and (cp2). (a) Similar solubilities
and (b) diﬀerent solubilities in solution where A=cp1+solvent, B=cp1+co-crystal,
C=co-crystal, D=cp2+co-crystal, E=cp2+solvent and F=solvent. This ﬁgure is
reproduced based on Blagden et al. work92.
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Many pharmaceutical co-crystals were generated using this method,
such as caﬀeine co-crystals with oxalic acid, malonic acid and glutaric acid24,
CBZ co-crystals with NCT and SAC95,96, and IND-SAC co-crystal26. The
growth of co-crystal from solution can be performed in the presence of micro-
crystals of the desired materials (seeding crystallisation). This approach is
designed to ensure that the desired crystals are always obtained. Seeding
often prevents the formation of kinetically preferable crystals and allows
those thermodynamically favoured to form97.
2.1.2 Slurry Preparation
This approach can generate co-crystal using small quantities of solvent. This
process creates a localized surface of dissolution suitable for components
to dissolve in, and form supersaturated phase which allows for co-crystal
formation. Pharmaceutical co-crystals prepared using this technique include
piroxicam with SAC and sulfamethazine with aspirin or benzoic acid98.
2.1.3 Mechanochemical Grinding Technique
It has been noticed that co-crystals can be prepared simply by grinding the
API with co-crystallising agents either dry (neat grinding) or in the presence
of solvent (kneading or liquid assisting grinding)99. The eﬀect of grinding
on producing co-crystals can be attributed to the mechanical stress and the
generated heat from the milling process. This mechanical process increases
the surface area of interaction between materials due to fractured crystals,
and enhances the interaction due to diﬀusion through such surfaces100. In
addition, it can result in local melting at the interface area, similar to the
eutectic phase i.e., the interaction between components occurs in a liquid
phase47,97,101.
The addition of small amounts of solvent during grinding (LAG)
creates an atmosphere of vapour pressure of the solvent, which along with
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the size of particles, and the length and the rate of milling contribute in
the formation of co-crystal. It has been found that the co-crystal grinding
method generates phases identical to those obtained by solution evapora-
tion. This can be interpreted by the inﬂuence of strong intramolecular bonds
on directing molecules to preferable crystalline form. However, solvent ef-
fects are still substantial in determining the rate of co-crystal formation,
types and stability of crystalline forms49. In fact, adding solvents in which
both components are dissolved enhances the kinetics process of grinding by
opening the scope of interference between molecules; and thus increasing
molecular collisions by means of adding additional degrees of orientation
and conformational freedom92,102. Overall, it was suggested that co-crystal
formation involves diﬀusion process through surface and this can be assisted
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co-crystal 
former
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co-crystal
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Figure 2.3: Mechanochemical grinding technique. It shows in (a) and (b) stain-
less steel jar with two balls used to contain the sample before mounted on Retsch®
Ball Mill (mixer mill MM400). This machine is available in B27 Boos Science
Building, School of Pharmacy, University of Nottingham. Grinding the API with
co-crystal former (c) leads to the formation of co-crystal (d).
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through another phase (solvent/gas) to various extent103105. The role of
mechanochemical grinding in molecular complexes is to activated the sur-
faces of reaction through defects or strains inducted by milling, and create
new surfaces by the redistribution and the movement process of molecules
and molecular products106 It has been reported that the use of LAG can
provide a control between the stoichiometric ratios and polymorphic forms
of co-crystal107,108. Theophylline and caﬀeine (β-form) are examples of APIs
co-crystallised with citric acid by neat grinding and in the presence of small
quantities of water63. Fig 2.3 shows the Ball Mill (mixer mill MM400) with
two stainless steel grinding jars accompanied by a diagram of co-crystal for-
mation using grinding approach.
2.1.4 Growth from the Melt
The principle behind this method is based on the fact that heating a mixture
of two or more solid phases leads to a direct meeting in a liquid phase at
their both lowest temperature. This temperature is called the eutectic point
and the phase they meet in is the eutectic mixture. If the eutectic mixture
of both components is capable to interact and exist in a distinct crystalline
form with diﬀerent properties, then a co-crystal is likely to seed from this
emergent phase after cooling the preparation109.
This concept was exploited in 1877 by M. W. Lehmann to prepare
mixed complexes in a mixedfusion experiment109,110. This experiment was
reﬁned in 1951, by L. Koﬂer and his wife A. Koﬂer, who investigated hun-
dreds of organic molecules using Koﬂer melt technology110,111 and it has
later been used to prepare pharmaceutical co-crystals such as ibuprofen,
FBP, fenbufen and salicylic acid with NCT by Berry et al.91. This ap-
proach involves placing a small amount of the higher melting component
on a lid-covered slide, heated until melting occurs, and then allowing to
solidify (ﬁg 2.4 I). The second component is then placed at the other edge
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Figure 2.4: Schematic diagram of Koﬂer fusion preparation. It shows the con-
sequential steps for preparing Koﬂer sample (I-IV) whereas the higher melting
component is (A), the lower melting component (B), melted (AB) and the co-
crystal is (C).
of the coverslip and melted. Once the second component melts, it slips
under the coverslip and becomes in contact with the ﬁrst component (ﬁg
2.4 II). Afterwards, the temperature is slightly raised to allow the second
component to be at the juxtaposed parts of ﬁrst component (ﬁg 2.4 III).
Finally, the entire sample is cooled and awaiting time is given to help initi-
ate the crystallisation of the new compound (ﬁg 2.4 IV). As a result, three
distinct crystalline phases appear; both of the starting components and the
new compound (co-crystal) along the zone of mixing.
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Figure 2.5: The binary phase-diagram of co-crystal formation. The temperature
is plotted vs the molar fractions of components (A, B). It displays in (a) the
melting of (A, B) at 100% of the starting components. Melting curves meet at
the lowest temperature called eutectic point. When both components are able to
recrystallise in a single crystalline phase, then a co-crystal (C) is formed as shown
in (b).
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This is explained in the binary phase diagram of this type of prepa-
rations (ﬁg 2.5). The curves in the phase diagram display the melting tem-
peratures at each molar fraction from ﬁrst and second components. These
curves start from the melting points (Tm) of pure components on both sides
and meet at the lowest temperature at a speciﬁc molar ratio, termed the
eutectic temperature (ﬁg 2.5 a). If both components are able to recrys-
tallise in a separated phase at this molar ratio, then another curve for the
melting point of co-crystal appears (ﬁg 2.5 b).
The purpose of studying temperature-composition diagram is to as-
certain whether or not a reaction takes place in molecular complex systems.
Similar measurements were conducted in studying nicotinamide-ascorbic
acid system59,112. However, not all of organic mixtures are capable to form
molecular complexes when melted mixtures are cooled. More than half of
organic compounds stay in a physical mixture form (ﬁg 2.6 blue), about
31.4% resulted in molecular complexes (ﬁg 2.6 red), while the rest belong
to amorphous form or so called solid-solution (ﬁg 2.6 green)113.
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Figure 2.6: The phase diagrams and the fraction of binary systems. Physical
mixtures are in (blue), molecular complexes are in (red), and solid-solution are in
(green).
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2.2 Pharmaceutical Co-crystal Screening
Co-crystals are generally investigated using diﬀerent techniques such as con-
ventional thermal analysis (diﬀerential scanning calorimetry and hot-stage
microscopy), vibrational spectroscopic technique (Raman spectroscopy in
its reﬂective and transmission modes), and crystallographic diﬀraction tech-
nique (x-ray powder diﬀraction and single x-ray diﬀraction). Since there is
no one adequate technique capable alone of yielding a comprehensive iden-
tiﬁcation for materials, it is important to collect data using more than one
strategy. Therefore, a description about the principle of employed tech-
niques and their commercial instruments will be explained in this section.
2.2.1 Diﬀerential Scanning Calorimetry
Conventional thermal analysis such as DSC is a widely common technique
in the R&D laboratories. It is used to understand the change in the physical
and chemical properties as a function of temperature or time. It is mostly
the ﬁrst step taken in the characterization studies of solid-state forms of an
API114. DSC is used to measure the change in the energy as the sample is
heated, cooled, or isothermally held. The main property measured by the
DSC is the heat ﬂow into the sample (endotherms) or out of the sample
(exotherms) as a function of temperature or time. It is important to take
into consideration the contribution of heat ﬂow from DSC pans and the
furnace. This is achieved by taking the diﬀerence in the heat ﬂow between
two pans; the ﬁrst pan contains the sample and the other one is an empty
pan used as a reference.
As heat is transferred to the pans, a thermocouple located under-
neath both stages monitors the diﬀerential heat ﬂow (ﬁg 2.7). Conse-
quently, the heat ﬂow which reﬂects studied substances is referred to by
△H and this is usually plotted as a function of temperature or time. The
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Figure 2.7: Diﬀerential scanning calorimetry DSC Q2000. The instrument ex-
ists in room C27 in Boots Science Building, School of Pharmacy, University of
Nottingham. It is accompanied with T-zero® DSC Sample Encapsulation Press
kit (top-left). The ﬁgure also shows the mechanisms of recoding thermal mea-
surements at the bottom.
heat ﬂow △H is equivalent to the changes in the enthalpy hence, it can
be used to measure the glass transition Tg event, crystallisation and phase
transitions, melting, and heat of fusion events. All research equipments
should undergo a regular calibration following the rules of good laboratory
practice (GLP) or any other regulation set by research unit. DSC calibra-
tion is performed in relation to the melting temperature and the enthalpy
of indium standard while the heat capacity is calibrated against sapphire.
TA Instruments DSC Q2000
TA Instruments DSC Q2000 (Crawley, United Kingdom) was employed to
screen the starting materials and the resulting compounds. It is supplied
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with 50-position auto-sampler which provides a ﬂexibility in arranging more
than one sample for measurement. It is equipped with DSC furnace with
two uplifted stages for placing the sample and the empty reference pans.
The furnace is provided with an auto-lid which works in coordination with
the auto-sampler. Both sample and empty reference pans are transferred
from the auto-sampler to the furnace by means of a robotic arm. Accord-
ingly, the automation and the coordination between equipment's compart-
ments enable for fast and eﬃcient measurements. The operating heat range
is (-40 to 400 °C). Sub-ambient operation is facilitated by a Refrigerated
Cooling System (RCS40), which allows for DSC standard and modulated
DSC (MDSC) operation over a temperature range of -40 to 400 °C. All
measurements are scheduled and recorded automatically using Platinum
software.
Samples are encapsulated using T-zero® DSC Sample Encapsulation
Press, The press kit includes 4 die sets convenient for hermetic or non-
hermetic sealing included in a black box kit with a tweezer and two boxes
of DSC pans and lids. Dies are colour coded in green, white, black, blue
which are compatible with T-zero or standard aluminum pans and lids;
Black dies (suitable for non-hermetic sealing T-zero aluminum pans and
lids) are the ones used in this research study (ﬁg 2.7).
2.2.2 Hot Stage Polarised Microscopy
Within the ﬁeld of studying solid-state properties of pharmaceuticals, micro-
scopic observation provides a rapid, and versatile, and often non-destructive
method for analysing samples. The characterisation provides information
regarding the physicochemical properties such as particle shape and size,
optical properties, crystallisation, dissolution behaviour, and thermal be-
haviour when the microscopy is coupled with the hot-stage compartment115.
Observing the thermal behaviour microscopically is obtainable using po-
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larised light thermoscopy, which was a method of interest along the course
of this research work. The principle behind polarised thermoscopy is de-
picted in ﬁg 2.8.
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Figure 2.8: Sketched diagram showing the principle of polarised thermoscopy.
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PriorLux Pol & Linkam DSC600
Thermoscopic investigation was observed using PriorLux Pol advanced po-
larised light microscope (PriorLux Pol, Prior Scientiﬁc, Fulbourn, Cam-
bridge, UK). PriorLux Pol (ﬁg 2.9) is equipped with a mechanical stage
of 360 degree rotation (1 degree increments) for placing sample. Samples are
focused through the collaboration of focusing eyepieces of 10× magniﬁca-
tion and 20 mm view ﬁeld, and free objectives of either 4×, 10×, 20×, 40×,
or 60× magniﬁcation. The focusing mechanisms (the co-axial and coarse
adjustments) are controlled with a tension control focus stop. Samples are
illuminated by a 12 V and 30 W halogen lamp with variable brightness
control. Kohler illumination can be controlled using iris diaphragm with
aperture size of 1.25 NA. The illuminated light can also be polarised using
a rotating polariser which is scaled and controlled by means of Bertrand
lens.
Figure 2.9: PriorLuxMET hot-stage polarised microscope exists in room C27 in
Boots Science Building, School of Pharmacy, University of Nottingham.
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Microscopic images are collected through a CCD camera attached to
the microscope. CCD digital camera can be either used in its still mode
for basic image capture, or in its advanced imaging mode for moving pic-
tures. The videos can be generated from consequetive pictures collected
at chosen time intervals using image capture software which is built within
the Linksys32 package. PriorLux Pol is equipped with a Linkam DSC600
heating-freezing stage. The latter is controlled by T95-Linksys temperature
programmer and Linksys32 software (Linkam Scientiﬁc Instruments Ltd.,
Tadworth, Surrey, UK) (ﬁg 2.9). Linksys32 package enables to control the
hot-stage and the temperature programs i.e., the thermal scanning proﬁle
over selected temperature range and heating rate (ﬁg 2.9).
2.2.3 Raman Spectroscopy
Raman spectroscopy is useful for studying the chemical structure of dif-
ferent systems from simple chemicals and plastics to biological structures.
It produces important information about physical properties such as crys-
tal form, crystal size and molecular orientation. Raman spectroscopy has
been recently combined with confocal microscopy and named confocal Ra-
man spectroscopy. The latter technique yields chemical and other informa-
tion about samples with a high spatial resolution. The high resolution was
achieved due to the focality of laser on the sample by means of objectives,
which collect and direct scattered light through a pinhole towards the de-
tector. Since confocal Raman spectroscopy is the technique of choice for
investigating heterogeneous systems on the micrometer scale, it is beneﬁcial
for studying co-crystalline forms.
Moreover, confocal Raman spectroscopy can also be attached to hot
stage, which is useful for investigating co-crystal kinetics and formation. For
instance, it was used for screening carbamazepine-nicotinamide synthesis116.
Raman spectroscopy is very important in detecting polymorphic forms and
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Figure 2.10: Schematic of the vibrational scattering showing the possible tran-
sitions between energy levels. It shows elastic scattering (Rayleigh scattering),
inelastic Raman scattering (Stoke and Anti-Stoke scattering).
distinguishing between the presence of polymorphs117.
Raman study involves the use of inelastic scattering of monochro-
matic radiation (photons) of energy suﬃcient to cause a distortion in the
electron distribution cloud of covalent bonds. In all types of spectroscopic
techniques, the instrument measures the changes in the energy of photon
(either lost or gained) resulted from the interaction between photons and
molecules within the sample. The nature of such change varies according
to the nature of inter/intramolecular bonds within studied compound, the
symmetry of its molecule, and the energy of incident light.115
Molecules are promoted to a virtual state when the distortion in the
distribution of electronic clouds occurs. When molecules relaxes, they re-
turn back to the ground state releasing acquired energy either in the same
frequency (Rayleigh scattering) or in a diﬀerent frequency (Raman scatter-
ing). Hence, Raman scattering is an inelastic scattering which its frequency
can be either less (Stoke scattering) or more (anti-Stoke scattering) than
the frequency of incident light, depending on the original vibrational state
of molecules. Most molecules exists in the ground state, this means that
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when substance are subjected to a suitable radiation, they scatter light in
Stoke mode. Such theory is simpliﬁed in ﬁg 2.10 which shows the electronic
transition between energy levels.118,119
Confocal Raman Spectroscopy (LabRAM HR Horiba)
Raman spectrometer LabRAM HR from Horiba Jobin Yvon (Villeneuve
d'Ascq, France) was utilised to screen and collect Raman spectra for samples
and their co-crystal preparations. This system is provided with four laser
lines 325 nm, 532 nm, 660 nm and 785 nm covering UV-VIS-NIR regions,
optics for coupling laser to the samples and carrying back Raman signal
through the spectroscopy. Raman signals are diﬀracted by the available
gratings (1800, 1200, 600 lines/mm and 1200 lines/mm for UV). In this
work 600 lines/mm gratings was employed. The dispersed signals were then
detected by a large 1024 pixel CCD detector cooled at -70 °C.
This instrument is equipped with an Olympus BX41 microscope pro-
vided with; a white light illumination system working by reﬂection or trans-
mission, a coloured camera to visualise the samples, XYZ motorized stage,
and a variety of lenses 10×, 100× and 40× (UV) and 50× LWD, 100×
LWD objectives. The ones used in this study were 10× and 50× LWD.
It is also supplemented with standard XY manual cooling/heating stage
(Linkam LTS350) with TMS94 temperature controlling programmer and
LNP94 cooling system and a 2 litre dewar for liquid Nitrogen. These ac-
cessories allow to heat, cool, or isothermally hold the sample, and acquire
Raman spectra as function of temperature. Hence, it enable to investigate
the chemical changes accompanied studied materials while subjecting sam-
ples to heating environment. Hot-stage accessories were provided by Linkam
Scientiﬁc Instruments Ltd (Surrey, UK).
There are other options to design the experiment using this instru-
ment, encompassing a measurement as a function of a space. For instance,
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Raman data can be acquired from a single point, or set up to record spectra
from diﬀerent sets of points which can be aligned in one line (line mapping),
or many lines in a square or circle form (XY mapping), It is feasible also
to run a 3D mapping by including the depth (XYZ mapping) (ﬁg 2.12).
All these operations are set up and acquired through LabSpec 5 software,
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Figure 2.11: LabRAM HR Horiba confocal Raman instrument. The instrument
is available in room B03 in the Nottingham Nanotechnology and Nanoscience
Centre (NNNC), University of Nottingham.
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Figure 2.12: Schematic of Raman measurements as a function of space. Mea-
surements can be recorded from diﬀerent points (single point spectrum) as shown
in (a), from a series of points aligned in a one line (line mapping) (b), many lines
(XY mapping) (c), or in 3D form (XYZ mapping) (d).
which is designed to control Raman instrument. The Raman system was
calibrated before acquiring measurements, on a standard silicon (Si) sample
after adjusting the spectrograph zero position, the silicon Raman peak is
within ±1 pixel of 520.7 cm.
2.2.4 Raman Data Analysis
Matlab 7.6.0 (R2008a) Software Package
Matlab 7.6.0 (R2008a) is a separate licensed mathematical workspace writ-
ten by the MathWorks, Inc. (MA, US). It was used in this work for principal
component analysis on Raman mapping data of FBP-NCT Koﬂer system.
Data were quantitatively simpliﬁed into sets of variables and linearly corre-
lated with the original data.
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R version 2.15.0
R is a separate free package designed by the R foundation for statistical
computing, R version 2.15.0 (30-03-2012), which was downloaded in ubuntu
12.04 LTS. Scripts with suitable codes (routines) were written for analysing
data using two statistical methods; principal component analysis and hier-
archical agglomerative clustering.
Multivariate Data Analysis
Multivariate data analysis is one of the eﬃcient algebraic approaches em-
ployed to simplify complex data, discriminate and classify between variables.
In the current work, three protocols were mainly employed to analyse Ra-
man and x-ray powder diﬀraction data.
1. Direct Classical Least Square Analysis: DCLS modeling allows
image generation from large datasets based on a model parameter
(i.e., spectrum). This model is predicted according to its similarity
with a reference. Afterwards, the correlation between observations
and a predicted model is calculated using the best-ﬁt methodology
based on minimising the sum of squared diﬀerences between obser-
vations and predicted model. Accordingly, observation with best ﬁt
with selected model are classiﬁed together and their degree of match
is worked out120. This method was adopted in chap 3.
2. Principal Component Analysis: PCA is one of the fundamental
methods in the statistical analysis of large datasets and it was em-
ployed in chap 3, 4, 5 for analysing Raman mapping and VT-Raman
data. PCA is a well established mathematical operation, through
which large number of observations are transformed by rotation into
a smaller number of orthogonal variables, known as principal compo-
nents, each of which is characterised by a score (single vector variable)
Aalae Alkhalil 38
Chapter 2 Preparation Methods & Screening Techniques
and a loading (as many variables exist in a single original dataset)121.
PCA can also be considered a clustering algorithm. It is useful for
the analysis of phase transformations chap 4. PCA results can be
presented as scores' plot (i.e., PC1 against PC2), and/or PC scores
against number of observation (i.e., PC1 against temperature), and/or
PCs loadings i.e., PC1 loadings against variable (wavenumber).
3. Hierarchical Agglomerative Clustering: In this method (HAC),
the diﬀerences or the similarity between data variables are calculated
and used to agglomerate and arrange datasets in a tree-like structure
or dendrogram. The distance between datasets can be calculated in
diﬀerent methods but the one used in this research work was based on
Euclidean method, afterwards the linkage between data was achieved
using Ward's method as demonstrated in chap 5.120
2.2.5 X-ray Crystallography
X-ray crystallographic techniques have been described as a gold standard
method to understand the crystal packaging, hydrogen bonding and struc-
tural conformation. When a sample is subjected to x-rays, each atom in its
unit cell interacts with the incident radiation resulted in x-rays diﬀraction
from all parts of the structure. Moreover, an interference similar to that
between electrons in an atom occurred between scattered x-rays. Therefore,
the overall diﬀracted x-rays represent the sum of individual unit cells.115
This perspective was visually simpliﬁed and mathematically valid by
W. L. Bragg, who considered x-ray diﬀraction as a reﬂection from set of
planes of diﬀerent indices (h, k, l) and have intensity Ihkl. These indices
are associated with atomic positions and other inﬂuencing factor of x-ray
scattering. He added that diﬀraction does not occur until Bragg's law is
satisﬁed (eq 2.1) which correlates between the wavelength of incident light
(λ), its angle with respect to the planes (θ), and the distance between the
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plane dhkl (ﬁg 2.13).115
λ = 2× dhkl × sinθ (2.1)
Equation 2.1: Bragg's equation whereas the wavelength of incident beam is λ,
the angle of incident light with respect to planes is θ, and the distance between
the planes is dhkl.
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Figure 2.13: Sketched diagram showing the principle of XRPD and beam diﬀrac-
tion according to Bragg's law.
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Bruker D8 Advance XRPD
X-ray powder diﬀraction (XRPD) is an analytical technique used for iden-
tifying crystalline phases and deﬁning unit-cell dimensions. It is also widely
used in the pharmaceutical industries as it provides a rapid mean for struc-
tural characterization. Thus, it can be used to determine co-crystals and
detect their formations. For example, the formation of caﬀeine-salicylic co-
crystal was conﬁrmed by using XRPD when compared with the calculated
patterns of pure components and co-crystal122. The formation of co-crystals
can also be tracked using XRPD when a mixture of components is subjected
to heating environment or so called variable temperatures (VT) resulting
in VT-XRPD experiment. For instance, XRPD patterns of a mixture of
caﬀeine and salicylic acid was taken at diﬀerent temperature points. It was
noticed that characteristic peaks appeared at 125 °C, 130 °C and 135 °C at
(12.1° and 13.4° 2θ) for the caﬀeine-salicylic acid co-crystal, and vanished
at 150 °C, around the melting point of co-crystal122.
The principle of XRPD technique is based mainly on generating x-
rays from evacuated tube, which is then collimated and ﬁltered before hit-
ting the sample. The loose powder of studied sample is ﬁlled in capillary
tube and mounted on goniometer in the preferred orientation. Diﬀracted
beam is then recoded by a suitable detector (ﬁg 2.13).
A Bruker D8 Advance powder diﬀractometer was the commercial
equipment utilised to collect powder patterns in a Debye-Scherrer geom-
etry. X-ray radiation was generated inside a ceramic x-ray tube from an
anode made of copper Cu in Kα spectral line at wavelength λ= 1.54059
Å. The diﬀractometer is equipped with a scintillation detector and Bruker
Kristalloﬂex generator set on voltage 40 kV and current 40 mA. Samples
were loaded in borosilicate glass capillary tubes BGCT with 0.7 mm bore
diameter, supplied by CTS Capillary Tube Supplies Ltd UK, and mounted
on the goniometer in a preferable orientation. DIFFRACplus software pack-
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age version 2.3 was used for data acquisition. Analysis was conducted using
terminal window under Unix system, through which the raw data were pro-
cessed to a format suitable for plotting.
Figure 2.14: Bruker D8 Advance powder diﬀractometer. The instrument exists
in room B15 at the School of Chemistry, University of Nottingham.
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2.2.6 Single X-Ray Diﬀraction (Bruker AXS)
The principle of single x-ray diﬀraction (SXD) is very comparable to that
of XRPD whereas x-rays are generated in a ceramic x-ray tube, then col-
limated and become monochromatic. The resulting x-ray beam is directed
on the single crystal sample. Single crystal is mounted on the goniometer
head which allows positioning the crystal in the centre of x-ray beam, and
the rotation of goniometer enables collecting x-rays from diﬀerent orienta-
tions. The cryo-cooling is often utilised to minimise crystal damage and
reduce background noise in the measurements. In crystallographic struc-
ture determination, it is important to collect sets of diﬀracted beams of Ihkl
intensities. Therefore, the intensities of diﬀracted beams are recored using
suitable detector (ﬁg 2.15).
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Figure 2.15: Sketched diagram showing the principle of single x-ray diﬀraction.
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Bruker Nonius Smart Apex CCD diﬀractometer (Bruker AXS LTD.,
Coventry, UK) is a single x-ray instrument used to mount the single crystal
of FBP-NCT co-crystal. X-ray radiation is generated inside a ceramic x-ray
tube from an anode made of Mo in Kα spectral line at wavelength λ=0.71073
Å. The diﬀractometer is equipped with a Bruker Kristalloﬂex generator set
on a voltage of 50 kV and a current of 40 mA, a graphite monochromator,
and an Oxford Cryosystem Cryostream (Oxford Cryosystems Ltd., Long
Hanborough, Oxford, UK).
2.2.7 Mercury 1.4.2 Package
Mercury package is a part of Cambridge Structural Database system. It
was used to visualise the crystal structure of the starting material and cal-
culate their powder diﬀraction data. Data were ﬁrstly obtained in a .CIF
format from the Cambridge Crystallographic Data Centre (CCDC) via the
CrystalWeb, then loaded in Mercury 1.4.2.
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Confocal Raman Mapping of
Koﬂer Co-crystal Preparation
3.1 Abstract
The spatial distribution of molecular and crystalline entities in a model
Koﬂer melt was for the ﬁrst time characterised using confocal Raman mi-
croscopy/spectroscopy. Direct classical least squares and principal compo-
nent analysis were used to generate hyperspectral maps. The long-standing
view that the Koﬂer method is suitable for rapid and reliable mapping of a
binary phase diagram is not supported from the results.
3.2 Introduction
Multicomponent solids are widely discussed in the context of a variety of ap-
plications in pharmaceutical, chemical and material ﬁelds34,123. Co-crystals,
in particular, have recently gained a great deal of attention in pharma-
ceutical area32,51. They have been adopted as an approach to modify the
properties of single-component materials, which have become a matter of
importance in drug development and delivery ﬁelds24,26,6971. Co-crystals
can be deﬁned as single-phase multi-component solid materials, where com-
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ponents coexist in stoichiometric ratios and are linked through non-covalent
bonds with the components remaining unionised48.
Few techniques have been employed to generate co-crystals, of which
solution screening is the dominant method of isolating new crystalline forms.
However, this can be complex when applied to co-crystal formation, espe-
cially for components of diﬀering solubilities56,124. This issue can be ad-
dressed by conducting the crystallisation from a melt, which avoids the use
of any solvent. An example of this is the use of the fusion contact pro-
tocol by means of the hot-stage microscopy125127. The concept of fusing
mixed compounds, based on the contact method, was originally described
by M. W. Lehmann in 1888128, which was later reﬁned by L. Koﬂer and A.
Koﬂer110 and called the contact method by W. C. McCrone111. In fact, the
use of the fusion contact protocol for screening co-crystals is not particularly
widespread and has remained unmodiﬁed since W. C. McCrone's work111.
However, it has been recently revisited by a few researchers such as Davis
et al.109, McNamara et al.129, and Berry et al.91.
The basic premise of the Koﬂer mixed fusion method is to allow
two components to meet between a glass microscope slide and a coverslip,
and form (by melting) a composition gradient. Subsequently the potential
formation of a co-crystal at this zone of melting is investigated by optical
microscopy. The fusion method can also be used to generate small seeded
crystals which can subsequently be used to grow larger crystals from solution
(suitable for structure determination by single crystal X-ray diﬀraction)56.
However, the main idea of using hot-stage microscopy in Koﬂer preparation
is to screen the melting behaviour of two component systems in a single
rapid and straightforward experiment, without the necessity to determine
their full phase diagram∗. The conventional theory of the observed phases
∗McCrone, 1951111: "the entire composition diagram is shown in the composition
gradient" ; Berry et al., 200891: "This zone is then comparable to the composition of the
binary phase diagram for two components."
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Figure 3.1: Schematics of the traditional component's position in Koﬂer melt
preparation and its binary phase diagram. (a) is the plot of molecular fraction vs
its position in Koﬂer melt slide, while (b) is the binary phase-diagram of the co-
crystal formation. The temperature in the phase diagram is plotted vs the molar
fractions of components (A and B, the higher and lower melting components,
respectively). It shows the co-crystal formation (C) from stoichiometric (A and
B) at 50%. It also displays the melting of (A, B) at 100% of each, Tm (A) and
Tm (B) respectively. It indicates to the meeting in the liquid phase between
component (A) and co-crystal (C), component (B) and the co-crystal (C) at the
lowest temperature or eutectic temperature as indicated by asterisks where the
intersection occurs in a wide and smooth style.
in an ideal Koﬂer experiment (ﬁg 3.1 a) assumes a linear composition
gradient across the zone of mixing after starting with 100% of the respective
materials at the peripheral sides∗ 56,91,111.
The co-crystal formation is potentially achieved from the liqueﬁed
mixture at any area within the contact region, provided that the composi-
tion of components exists at a suitable molar ratio for the crystallisation of
single-phase form (typically 1:1, 1:2, 2:1 or other commensurate ratio). This
formation is separated from the components present at the peripheral sides
with solidiﬁed eutectic mixtures existing at diﬀerent ratios. Thus, Koﬂer
melt preparation allows a rapid qualitative mapping of the phase diagram
as outlined in ﬁg 3.1 b.56,110
∗Berry et al., 200891: "with one side of the mixing zone representing 100% of one
component and the other side 100 % of the other component, and with a concentration
gradient across the zone." ; Davis et al., 2004109: "At some point in the mixing zone,
there should be a 1:1 ratio of the two components. Moving from this point toward ei-
ther pure component, the proportion of that component increases. Thus, a composition
gradient exists across the mixing zone." ; and this was pictorially illustrated by Kuhnert-
Brandstatter, Figs 6 and 7. Kuhnert-Brandstätter M., in "The status and future of
chemical microscopy" from Pure and Applied Chemistry, 1965130.
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Despite all the beneﬁts of traditional hot-stage microscopy in Koﬂer
mixed fusion preparations, there are some serious limitations of this method
in achieving full qualitative and quantitative characterisation. One severe
limitation is that the hot-stage microphotographs often cannot unambigu-
ously identify the phases present, as their interpretation depends on visual
inspection. Therefore, such investigation is subjective and cannot be used
for example to unequivocally identify phases. Therefore, it was proposed
that such imperfections could be overcome by the use of spectroscopic map-
ping techniques for screening the Koﬂer melt.
Because the sample is held between a cover slip and a glass micro-
scope slide, infra-red mapping methods such as contact method attenuated
total reﬂectance IR (ATR-IR) are inappropriate as the Koﬂer melt is not
directly accessible. Therefore confocal Raman microscopy was employed,
which can be performed in a non-contact and confocal manner118, in this
study to investigate the spatial distribution of chemical and crystalline en-
tities in a Koﬂer melt.
Raman spectroscopy/mapping is a well-established technique and is
widely employed in many ﬁelds including pharmaceuticals119,131. It is typ-
ically used to provide information on the molecular nature of the sample
by employing the spectral window 400  4000 cm-1, which covers the en-
ergy range of intra-molecular vibrations. However by employing the lower
energy phonon-mode bands (10  400 cm-1), it is possible to probe the
inter-molecular vibrations and thereby obtain detailed information about
the solid-state characteristics of the sample, including polymorphism132,133.
Phonon-mode data have recently been employed in generating Raman maps
of spatially distributed polymorphs in molecular semiconductors134, where
they proved to be more sensitive to crystalline packing than the traditional
intra-molecular bands.
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Figure 3.2: Schematic of chemical structure of ﬂurbiprofen (left) and nicoti-
namide (right).
In the present study, confocal Raman spectroscopy/microscopy was
employed to study the molecular and crystalline nature of a model Koﬂer
melt system through both phonon-mode and intra-molecular bands. The
study provides detailed insight into the applicability of the Koﬂer method
for co-crystal screening and represents the ﬁrst application of spectroscopic
mapping method to a Koﬂer melt. The phonon-mode Raman data on the
co-crystal are also the ﬁrst example of the application of this emerging
spectroscopic technique to characterising co-crystals.
The well-characterised model system ﬂurbiprofen  nicotinamide,
which was previously investigated by Berry et al. using standard hot-stage
microscopy, was selected for this study. The characterisation in the Berry
et al. study was based on standard hot-stage optical microscopy, which
provided clear evidence for four separate phases in the FBP-NCT system;
the co-crystal, FBP, and two NCT polymorphs91. Thus, the motivation was
to use this system as a model in the spectroscopic mapping study. FBP is
used as an active pharmaceutical ingredient and NCT is the co-crystallising
agent. FBP (ﬁg 3.2, left) possesses a carboxylated group in its struc-
ture while NCT (ﬁg 3.2, right) has a pyridyl ring and amide group in its
structure. Both groups allow NCT to serve as a complementary co-factor
to FBP.
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3.3 Experimental Section
3.3.1 Instruments
Raman spectral data were acquired using a LabRAM HR system (Horiba
Jobin Yvon), a 600 lines/mm grating, a 532 nm laser source and a 50×
objective lens and a Synapse thermo-electrically cooled CCD. Temperature
control was achieved using a Linkam LTS350 hot-stage. The system was
calibrated before acquiring measurements on a standard silicon, as well as
the Rayleigh line. The silicon Raman peak was within ±1 pixel of 520.7
cm-1. The grating was ﬁxed to allow relatively rapid mapping, at the ex-
pense of a slightly restricted spectral range. Such combination improves
the quality of data achieved through this instrument and allows for an ac-
cess to the phonon-mode spectral window (30  400 cm-1) as well as the
higher wavenumber region (400  4000 cm-1) which provides information
on the traditional intra-molecular bands. Thereby, both the intramolecular
and intermolecular spectral information could be obtained. The mapping
was automated by an XY stage and set up to cover a grid of (1535 µm ×
1619 µm) at 25 µm steps. 4030 Raman spectra were acquired based on an
acquisition time of 3 sec/spectrum.
3.3.2 Materials
FBP and NCT were purchased from Sigma-Aldrich (Poole, UK) and were
used as received. X-ray powder diﬀraction conﬁrmed that they were of
form I crystalline state when compared to patterns obtained from CSD (li-
brary Reference codes are FLUBIP, and NICOAM03, respectively)135,136.
They were also found to melt as per literature by DSC (114.01 °C and 128.24
°C, respectively)87,137.
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3.3.3 Koﬂer Preparation
The process of Koﬂer melt preparation was carried out by placing a small
amount of NCT on a glass microscopic slide under a coverslip. This was
heated until melting occurred at around 130 °C, and then allowed to solidify.
FBP was later placed at the opposite edge of the coverslip and melted at
around 115 °C. Once melted, it was drawn by capillary action under the
coverslip dissolving the juxtaposed part of the NCT. The temperature was
slightly raised and the sample was held at which for 5 min. The whole
preparation was then allowed to cool and kept at RT to solidify. All of
these experiments were performed at room temperature. Therefore, the
entire samples and the various interfaces identiﬁed are static.
As a pre-mapping procedure, Raman spectra were taken from the
melted starting materials (FBP form I and NCT) and from their equimolar
melted mixture. These Raman spectra were taken under the same condi-
tions as for the Koﬂer preparation and therefore used as references. Raman
spectra of the starting materials NCT and FBP form I, FBP form II, and co-
crystal at the zone of mixing were acquired and used for assigning principal
components' loadings to their original components.
3.3.4 Direct Classical Least Squares Analysis
Spectral data sets were subjected to baseline correction and mean normal-
ization before carrying out DCLS analysis of the melted region. DCLS maps
were generated by employing a limited number (n) of selected spectra to
form a linear combination, which was then used to model all of the spectra
in the Raman spectral image. The modelling is achieved through a best-
ﬁt methodology. The sum of the (n) components would not often be able
to model 100% of a given spectral pixel in the image which is expressed
by an error (ε) as shown (eq 3.1). Both the molecular composition and
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Y(v×m) = K ×X(c×m) + ε (3.1)
Equation 3.1: Classical least square ﬁtting model. Through this equation, a
number of spectra (m) at a speciﬁc v-wavenumber of composition (c), arranged
into Y matrix (v×m), are classiﬁed according to each representative spectrum (n)
into a column of concentration matrix X (c×m) with a matrix of sensitivity K
and an error of ε.
the crystalline form were of interest in a Koﬂer melt, and were investigated
through employing the selected numbers (n) in particular spectral windows
for the analysis. Setting n=2 would correspond to FBP and NCT molecules,
whereas setting n=3 refers to the crystalline forms FBP, NCT, and a poten-
tial co-crystal. In addition to the number of spectra selection with which the
DCLS model was created, there is also a choice of spectral window selection
in which DCLS modeling was performed; in particular, the phonon-mode
region (30  400 cm-1), the molecular stretching region (400  1721.6 cm-1),
and the entire wavenumber region (30  1721.6 cm-1).
3.3.5 Principal Component Analysis
Maps were also generated using PCA in the spectral regions mentioned
previously in Matlab 7.6.0 (R2008a). Unlike DCLS which requires refer-
ence spectra for modeling experimental data, PCA predicts these models
instead. PCA simpliﬁes the data into sets of variables, which are linearly
correlated with the original data. It characterises the variances in data by
creating uncorrelated axes leading to transformation in the original coordi-
nates. The axis that gives the highest variance between original data refers
to the ﬁrst score, the one with consequent variance is the following one, and
so on138. Raman spectral proﬁle data were split into individual spectra,
baseline corrected under LabSpec 5 software and imported in text format
into Matlab 7.6.0 (R2008a).
Each variable was divided by the standard deviation of its Raman
spectrum, and all original data were mean normalized prior to PCA anal-
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ysis. PCA scores were rescaled to represent their intensities and used af-
terwards to create red-green-blue (RGB) colour-map. Images areas with
positive scores were assigned red derivative colour while negative ones were
in blue. The ﬁrst three principal components (PCs) were selected in this
study having statistically signiﬁcant values accounting for > 93% of vari-
ation. Loadings were compared with Raman spectra of NCT, FBP form I
and II, and the spectrum extracted from the zone of mixing.
3.4 Results and Discussion
3.4.1 Koﬂer preparation
Several attempts were carried out in order to achieve the required Koﬂer
preparation, involving the sample hold for a time above the eutectic temper-
ature before being fully solidiﬁed. The formation of a suitable Koﬂer melt
for later analysis was conﬁrmed optically (ﬁg 3.3 a). The visual inspection
shows clearly the existence of at least three crystalline phases in the Koﬂer
melt, assigned as NCT, FBP, and co-crystal.
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Figure 3.3: Fusion method preparation of FBP-NCT. Shown in (a) is Koﬂer
preparation after cooling which includes in the peripheral regions, FBP (left) and
NCT (right), and the zone of mixing at the centre in between, all are indicated
by arrows, while (b) is Raman spectra extracted from the three optically distinct
regions; NCT (green), co-crystal (blue), and FBP (red).
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This was also chemically proven when investigating their Raman
spectra acquired from the three optically diﬀerent regions (ﬁg 3.3 b). Each
of these spectra, referring to NCT, FBP, and co-crystal from Koﬂer prepa-
ration, was in a good agreement with the referenced samples prepared sep-
arately from a fusion procedure in which the composition gradient was not
generated (ﬁg A.1).
3.4.2 Raman Mapping
Raman mapping of the NCT-FBP Koﬂer melt preparation was conducted
following the optical and spectral conﬁrmation of the preparation and its
data were analysed by means of DCLS and PCA. For the DCLS analysis,
a number (n) of representative spectra exhibiting similar features to the
pure components were needed as an input for generation of the DCLS map.
Such requirement was achieved by extracting spectra from the mapping data
and comparing them to the reference samples of NCT, FBP and co-crystal
prepared separately from the melt. Fig 3.3 b shows the possibility of using
any of the spectra extracted from the three optically diﬀerent regions as
representative models. The point was made after conﬁrming the similarity
of extracted spectra to the referenced samples (ﬁg A.1, A.2).
Two (n) selections, n=2 and 3, were designated to probe the molec-
ular and crystalline species, respectively. The selection n=2 refers to the
starting (molecular) materials NCT and FBP, while n=3 alludes to the ex-
pected crystalline materials; the emerging phase (co-crystal) in addition to
both crystalline starting materials.
In addition to the number of DCLS components selection and for the
purpose of addressing the spatial distribution of molecular and crystalline
entities, three selected spectral windows were employed in these analyses.
The traditional intra-molecular spectral window (400  1721.6 cm-1) is ex-
pected to be most sensitive to the molecular composition of the samples,
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whereas the phonon-mode data (30  400 cm-1) are expected to be more
sensitive to the crystallographic nature of the samples. An analysis of the
entire spectral range for comparison is also presented.
Direct Classical Least Square Analysis n=2:
Maps generated from a DCLS analysis with n=2 (i.e., maps achieved from
reference spectra for NCT and FBP only) in the three spectral regions are
indicated by two colours (green and red) along with their representative
spectra as presented in ﬁg 3.4. All three maps exhibit at least two well-
deﬁned regions which are separated by vertical boundaries (ﬁg 3.4, top
row). The comparison of the optical image (ﬁg 3.3 a) with the DCLS maps
at n=2 indicates that the left-hand region in the DCLS maps corresponds
to FBP plus co-crystal, and the right-hand to NCT only.
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Figure 3.4: DCLS maps at two number of selection n=2. Two-component maps
(scores and their corresponding models) are presented in three columns (a → c),
each column consists of two rows (top row refers to scores while the bottom one
is related to their corresponding models). Maps (scores & models) generated in
the phonon-mode region 30  400 cm-1 are given in (a) column, the molecular
region 400  1721.6 cm-1 in (b) column, and the entire spectral range in (c)
column. The colours of scores and their models in the peripheral regions refer to
the compositions of the higher (green) and lower melting components (red).
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DCLS maps conducted at the three spectral regions are in general
rather similar. However, some diﬀerences are apparent on closer inspection.
For example, there is an evidence of a third region running vertically down
the middle of the image in the map generated from the phonon-mode spec-
tral window data (ﬁg 3.4 a), and to a lesser extent in the map generated
from the molecular stretching and the entire spectral windows (ﬁg 3.4 b,c).
This region corresponds to the co-crystal, which was again deducted from
the comparison to the optical image in (ﬁg 3.3 a). Note that a reference
spectrum for the co-crystal was not included into the input for map gener-
ation, and thus it is slightly surprising that the co-crystal can be identiﬁed
from these maps.
In contrast to the phonon mode map, the co-crystal is not readily
apparent from inspection of the map generated from the intra-molecular
spectral range. Overall, for the n=2 DCLS map generation, the presence
of the co-crystal is most clear in the phonon-mode data, and this is in
accord with the phonon-mode data being more sensitive to the nature of
the crystalline phase(s)81,133.
Direct Classical Least Square Analysis n=3:
Similarly, DCLS maps were generated when n=3 using all spectral ranges
(i.e., the input of spectra herein refers to FBP, co-crystal and NCT) (ﬁg
3.5). The three spectral ranges were similarly employed to generate sep-
arate maps (ﬁg 3.5 a,b,c). All three maps exhibit three distinct regions
which correspond (from left to right) to FBP, co-crystal and NCT. Again
the maps are similar in broad terms, but diﬀerences emerge on detailed
inspection. In all three maps the interface co-crystal:NCT is very distinct,
with the FBP:co-crystal interface being less discrete. This clearly indicates
that the composition gradient is diﬀerent in nature at these two interfaces.
The FBP:co-crystal interface is less distinct in the map generated from
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Figure 3.5: DCLS maps at three number of selection n=3. Three-component
scores and their models are given in (a → c), each column consists of two rows
(top row refers to scores while the bottom one is related to their corresponding
models). Maps generated in the phonon-mode region 30  400 cm-1 are given
in (a), the molecular stretching region 400  1721.6 cm-1 in (b), and the entire
spectral range in (c). The colours of scores in the peripheral regions refer to
the compositions of the higher and lower melting components (green and red,
respectively) while the one at the zone of mixing (blue) refers to the co-crystal as
shown also in their models.
the molecular data (ﬁg 3.5 b) and the entire spectral region (ﬁg 3.5 c)
than in the phonon-mode data (ﬁg 3.5 a). The molecular conformation of
FBP-NCT appears to be similar to those in both FBP and NCT unlike the
diﬀerences in the holding intramolecular forces as manifested in the phonon
region (ﬁg 3.5 a). The obvious interpretation of this is that the molecular
composition gradient is relatively smooth, whereas the crystalline compo-
sition gradient is relatively sharp. This is expected for a Koﬂer melt, in
which a molecular composition gradient is used to isolate a co-crystal of a
particular composition. The co-crystal is expected only to form in a limited
composition range, and the observed results are fully in accord with this.
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Composition Gradient:
The diﬀerences in the nature of the interfaces in the FBP:co-crystal, and the
co-crystal:NCT was commonly noticed in analyses generated for all spectral
windows (ﬁg 3.5 a,b,c). This suggested the possibility of investigating the
composition gradient across the Koﬂer melt preparation, an issue that has
not been addressed in others' work91,109,111. Fig 3.6 shows the averaged per-
centages of the existing components, taken from eight horizontal lines across
the preparation, calculated from DCLS when n=3 at the phonon region, the
molecular region, and the whole wavenumber window, respectively.
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Figure 3.6: Composition gradient deduced from DCLS using three components
selection n=3 in three spectral windows; phonon, molecular stretching and entire
wavenumber region as shown in a, b, and c, respectively.
The relative amounts of material from such analysis do provide a
good guide to the nature of the composition gradient if not the exact val-
ues of the composition. Analysis performed at the three spectral regions
(ﬁg 3.6 a,b,c) all show that the composition gradient of both starting
components was not ideally linear, especially towards the higher-melting
component (NCT). This is clearly noticed from the obvious sharp descent
in NCT concentration and the sudden rise of co-crystal concentration. How-
ever, there is a gradual decrease/increase in components' concentration at
the FBP/co-crystal interface. The reason for this can be deduced by consid-
ering the manner in which Koﬂer melt is prepared and studied. Conceptual
perspective on such ﬁndings is proposed by taking into consideration the
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Figure 3.7: Schematic of proposed sequence of events in the formation of a
Koﬂer melt in (I-IV). It shows the consequential steps for preparing Koﬂer sample,
whereas the higher melting component is (A) shown in green, the lower melting
component is (B) shown in red, and the co-crystal is (C) shown in blue.
sequential events of Koﬂer preparation (ﬁg 3.7 I-IV):
1. The highest melting material (NCT) was oﬀset to one side, once it
solidiﬁed after being melted (ﬁg 3.7 I);
2. Later on, the lower melting material (FBP) was melted when brought
into contact with the juxtaposed part of the higher melting material
(NCT) (ﬁg 3.7 II);
3. The lower melting material dissolved some solidiﬁed parts of the higher
melting component (NCT) at the contact area, while the rest of parts
remained inaccessible. This is analogous to the eﬀect of tides on the
seashore whereas the powerful sea waves erode only the facing coastal
features, depositing the washed sands oﬀshore (ﬁg 3.7 III). This
phenomenon was clearly demonstrated from DCLS results, which re-
vealed the discontinuity of the component distribution in NCT region.
Thereby, the higher melting component forms an area with a very dis-
tinct border at the interface with the zone of mixing.
4. Finally, the higher melting material (NCT) portions already dissolved
to saturation point in the liqueﬁed lower melting component (FBP),
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would crystallise forming a stripe of co-crystals along the contact area.
Some detached NCT particles and unsolidiﬁed co-crystal might diﬀuse
in the lower melting material (FBP), depending on how fast the lower
melting component crystallises (ﬁg 3.7 IV).
The obviously diﬀerent nature of the two interfaces observed in this work,
reﬁnes the traditional vision of a linear composition gradient in Koﬂer prepa-
ration. Such results (ﬁg 3.6) unambiguously demonstrate that a linear
composition gradient does not form, and indeed on detailed consideration
of the process of forming a Koﬂer melt, it is not expected to form. This is
illustrated schematically in ﬁg 3.7, in which the traditional vision of the
Koﬂer melt preparation.
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Figure 3.8: Schematics of new perspective about ingredient's position in Koﬂer
melt preparation and its binary phase diagram. (a) is the plot of molecular
fraction vs its position in Koﬂer melt slide, while (b) is the binary phase-diagram
of the co-crystal formation. The temperature in the phase diagram is plotted
vs the molar fractions of components (A and B, the higher and lower melting
components, respectively while C is the co-crystal). The intersection occurs in a
sharp form only in the melting component section (intermittent green line).
It shows the direct interface of the higher melting point solid with
the rest of the preparation, instead of a linear composition gradient causing
to a sharp change in the composition. This ﬁnding has important impli-
cations for the use of the Koﬂer melt as a screening method for co-crystal
formation. In particular, the step change in the composition of the prepara-
tion by the highest melting component will restrict access to this part of the
phase diagram (ﬁg 3.8, intermittent line). Thus, any potential co-crystals
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with compositions rich in the highest-melting component may not be exper-
imentally accessible. The composition range which is rendered inaccessible
will depend on a number of factors, the most important of which is likely to
be the amount of time spent by the lower-melting liquid in contact with the
higher-melting solid. The longer this time is, the more the chance is for the
higher melting solid to dissolve into the lower melting liquid, and the more
likely for the sharp change in composition at the interface to be reduced.
Thus, DCLS ﬁndings represent an important step forwards in understand-
ing the crystal growth in Koﬂer melts, which would be diﬃcult to quantify
without the use of Raman microscopy technique.
Principal Component Analysis:
Finally, the principal component analysis was the second chemometric meth-
od employed for Raman mapping analysis. Such an approach derives a num-
ber of independent linear combined variables that has suﬃcient information
about the original chemical data without the interference of operators or
the requirement for referenced spectra to model hyperspectral data on.
The ﬁrst three principal components were selected for this study (ﬁg
A.3), whose scores were heavily loaded by the presence of compounds in
the three optically diﬀerent regions, as shown in ﬁg 3.9. These components
displayed a homogeneous distribution of pure composition in the higher
melting region, which forms a very distinct boundary once reaching the zone
of mixing. In contrast to the higher melting region, PCA results highlighted
the non-uniformity in the distribution of components in the lowest melting
region and its unclear boundary with the zone of mixing region.∗ The
homogeneous composition in the higher melting region was clearly conﬁrmed
by studying the ﬁrst principal component (PC1) (ﬁg 3.9 a, scores). The
∗ PCA scores of the ﬁrst three components were used to create red-green-blue (RGB)
colour-map (ﬁg A.4), which shows similar feature to DCLS outcomes at n=3.
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ﬁgure shows that PC1 was positively weighted only by NCT (ﬁg 3.9 a,
loadings). Alternatively, the lower melting region displayed heterogeneity
in components' composition. Such an issue was proven by investigating
PCs' loadings. Fig 3.9 b,c show that components' weight on PC2 and
PC3 refer to both FBP and co-crystal.
  
PC1 loadings PC2 loadings
NCT
FBP I
FBP I
FBP II
(c)    PC3 Scores & Loadings
FBP II
Co-crystal
FBP I
PC3 loadings
PC3 ScoresPC2 ScoresPC1 Scores
(b)    PC2 Scores & Loadings(a)    PC1 Scores & Loadings
Raman Shift cm-1 Raman Shift cm-1Raman Shift cm-1
P
C
2
 L
o
a
d
in
g
s
P
C
3
 L
o
a
d
in
g
s
P
C
1
 L
o
a
d
in
g
s
x-position ( x25 µm) x-position ( x25 µm)x-position ( x25 µm)
y
-p
o
s
it
io
n
 (
 x
2
5
 µ
m
)
y
-p
o
s
it
io
n
 (
 x
2
5
 µ
m
)
y
-p
o
s
it
io
n
 (
 x
2
5
 µ
m
)
Figure 3.9: PCA analysis results. The ﬁrst three PCs' scores and their corre-
sponding loadings are shown in a, b, and c. Scores are in top row while bottom one
refers to their corresponding loadings. Loadings comparability to Raman spectra
of NCT, co-crystal, FBP I, and FBP II was checked in Fig A.5.
However, PCA loadings exhibited some positive weights speciﬁcally
on PC2 which did not initially match with any of the referenced spectra
(ﬁg A.5). These loadings, occurring strongly in the left-hand side of the
images and do not correspond to FBP form I, alerted to the likelihood
of polymorphism of this component. In this context, three diﬀerent poly-
morphs of FBP have been reported in the literature; form I is the most
stable form, form II could be induced by heteronucleation approaches with
polymers and it could also be prepared from seed solutions. However, it is
less stable than form I as it transforms to form I at around 90° C. The third
form is the least stable, although it is stable between a slide and a coverslip.
Moreover, it has been reported that the three forms can be simultaneously
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crystallised from melt-quenched FBP form I.87,139,140 Fig A.6 conﬁrms the
similarity of reference spectra for FBP forms I and II∗ to those extracted
from two diﬀerent pixels in the Koﬂer melt preparation. It clearly indicates
that polymorphism of FBP does indeed occur in prepared Koﬂer system.
Thus, PCA analysis was an eﬀective exploratory tool for data inter-
pretation especially when compared to DCLS. It revealed unexpectedly to
the presence of polymorphism in FBP, which has not been noticed in DCLS
approaches. The apparent lack of DCLS selectivity to the polymorphism
of FBP is in fact purely an operator issue as the input of spectra for the
two polymorphs of FBP into the DCLS map generation was not included,
as such observation was not expected to occur.
With the beneﬁt of hindsight, even the optical image (ﬁg 3.3 a)
presents some evidence of FBP polymorphism through the lower visual ho-
mogeneity of the FBP than the NCT, although this lower visual homogene-
ity is easy to mistake for larger diﬀerences in crystal habit and orientation
when compared to NCT. Although NCT is well known to exhibit polymor-
phism91, no evidence for the presence of more than one crystalline form of
this molecule in such work was observed.
Overall, both multivariate approaches used in this study were invalu-
able. DCLS analysis was beneﬁcial for yielding quantitative information.
However, this needs to be preceded by a knowledge of all existent forms,
which is not required for PCA analysis. Thus, both chemometric techniques
yielded advantageous interpretation of the hyperspectral data as they could
be served to quantify and characterise all crystal forms in the model Koﬂer
melt.
∗The single crystal structure of FBP form II was achieved in an attempt to prepare
FBP-NCT co-crystal from solution (ﬁg A.7).
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3.5 Conclusion
The work presented herein (chap 3) outlines the ﬁrst use of confocal Raman
microscopy to characterise Koﬂer melt preparations. This was shown to be
valuable in generating detailed information on the investigated phases and
providing qualitative information about the newly formed phases (co-crystal
and component's polymorphs).
Detailed quantitative and qualitative information from Raman map-
ping were achieved with the use of chemometric approaches. In this work,
two chemometric methods (DCLS and PCA) were explored to investigate
the spatial distribution of the components, and restricted spectral ranges
were employed to characterise the molecular and crystalline natures of the
Koﬂer preparation.
The use of DCLS analysis provided a new perspective regarding the
composition gradient present in Koﬂer melt preparations. It was shown that
the composition gradient is not linear as a function of position as had been
assumed until now. Rather, a sharp interface exists at the interface of the
highest melting component and the co-crystal. This sharp interface restricts
access to the binary phase diagram in Koﬂer preparation at compositions
rich in the highest melting component. It is now advisable, according to
work observation, to leave Koﬂer preparation as long as possible at high
temperatures over the melting point of both components in order to allow
the highest melting solid to dissolve in the liquid of the lower melting com-
ponent, and thus to reduce as far as possible the inaccessible region of the
binary phase diagram. In contrast to DCLS, PCA has not only conﬁrmed
the distribution of components but also revealed the presence of both FBP
polymorphic forms (form I and II), which had not been deduced from the
traditional method of optical observation nor from DCLS modelling.
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Figure 3.10: Conclusion ﬁgure of Koﬂer melt system.
It is also worth mentioning the sensitivity of screening with respect
to the crystalline components which was strongly enhanced by considering
the phonon-mode data (30  400 cm-1). Raman screening at this region
is a highly promising method for investigating in-situ crystallisation, poly-
morphs, co-crystals and solid dosage forms. This is attributed to its signiﬁ-
cant sensitivity in probing the crystalline structure of molecular compounds.
In conclusion, the use of Raman mapping was advantageous for inves-
tigating the nature and composition of phases in Koﬂer preparation which
was nearly impossible in the past. From this work, coupling the hot-stage
with Raman microscopy provides new insight into the use of Koﬂer method
to screen co-crystal formation and investigate the composition of ingredients
(ﬁg 3.10).
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The Study of FBP-NCT
Co-crystal Polymorphism
4.1 Abstract
Previous Raman microspectroscopic studies of FBP-NCT Koﬂer prepara-
tion showed the emergence of diﬀerent crystalline phases of FBP-NCT co-
crystal along the zone of mixing over a time of RT storage. Thereupon,
the aim was to build a clearer understanding of the solid-state behaviour
of FBP-NCT co-crystal, and more speciﬁcally investigating the potential
presence of FBP-NCT co-crystal polymorphs. Polymorphic screening, in
this chapter, was accomplished using classical thermal methods (diﬀerential
scanning calorimetry and the hot-stage microscopy), and parametric analyt-
ical techniques whereby Raman and x-ray diﬀraction data were collected as
a function of temperature (VT-Raman and VT-XRPD experiments). Stud-
ies were also supported by the crystal structure of FBP-NCT. The single
crystal were grown from a supersaturated solution of solvent-drop ground
product of 1:1 FBP-NCT.
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4.2 Introduction
Co-crystals have recently gained a great deal of attention in the pharma-
ceutical context32,51. They represent the latest approach in the solid-state
ﬁeld to modify the physicochemical and mechanical properties of single-
component materials. Such properties i.e., solubility, stability, hygroscop-
icity, morphology and ﬂowability, are a matter of importance in the drug
development and delivery ﬁelds22,24,26,27,29,6971,141145. The modiﬁcation of
such properties can be achieved by linking the API with various co-crystal
formers through non-covalent bonds. Such linkage yields multicomponent
systems of speciﬁc stoichiometric ratio of interactions and packing forms48.
The type and the right ratio of interactions, which are mostly dependent
on the interaction between complementary functional groups and the struc-
tural arrangements of ﬁnal compound, play an important role in achieving
a pharmaceutical co-crystal of the desired properties.
The issue of understanding the right ratio of interactions and the
favoured form of crystallisation become a subject of recent interest107,146,147.
These aspects have been invested to widen the scope of achieving a prod-
uct with the desired properties; not only by varying co-crystal formers
but by investigating the potential polymorphic forms of the API-cocrystal
agent34,51,68,148,149. However, such diversity in the solid-state forms the API-
cocrystal agent can be a hindrance in the drug production and formulation
processes if it is uncontrolled i.e., the simultaneous presence of co-crystal
polymorphic forms in the ﬁnal pharmaceutical product. Thus, a suﬃcient
understanding of the potential forms in multicomponent systems, their sta-
bility and the transformation process should be built up during the develop-
ment & manufacturing process28,123,150152. These prospects are important
for setting up controlled strategies to achieve co-crystals with the desired
drug properties either in their novel or patented forms153.
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Most polymorphic studies were related to single component sys-
tems154,155, however few studies have been very recently employed on molec-
ular complexes such as co-crystal systems31,134,156158. Within the ﬁeld of
polymorphic co-crystals, few researchers showed the feasibility to control
the formation and the interconversion between forms using various tech-
niques such as liquid assistant grinding30,46,99,158164. However, very limited
work illustrated the usage of thermal techniques coupled with spectroscopic
and crystallographic screening to probe the conversion between polymorphic
co-crystal forms116,161,165,166.
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Figure 4.1: Schematic of FBP-NCT Koﬂer system; co-crystal formation and
transformation.
The work presented in this chapter was motivated by an observation
of co-existent forms of FBP-NCT co-crystal previously prepared using Koﬂer
method (ﬁg 4.1). Thereby as a part of continuing previous study (chap 3)
on a model co-crystal system FBP-NCT, a full investigation was performed
to characterise FBP-NCT co-crystal polymorphs. Polymorphic screening
involved using thermal techniques (DSC and HSM), spectroscopic (Raman
spectroscopy), and crystallographic (XRPD) studies. Raman and XRPD
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parametric measurements were performed as a function of temperature, and
the resulting data were analysed by means of chemometrics (PCA). Finally,
the crystal structure of FBP-NCT co-crystal was calculated based on single
crystals which were grown in acetonitrile solution.
4.3 Materials and Methods
Materials FBP and NCT were purchased from Sigma-Aldrich (Poole, UK)
and used as received. They were conﬁrmed to be of form I crystalline
state from XRPD135,136. Diﬀerential scanning calorimetric scans conﬁrmed
their melts to be as in literature (113.55 °C and 128.14 °C, respectively ﬁg
B.3)87,137. The analytical grade acetonitrile solvent (ACN) was supplied by
Fisher Scientiﬁc (Loughborough, Leicestershire, UK).
4.3.1 Conventional Thermal Screening
DSC Studies:
The thermal behaviour of the starting materials and 1:1 FBP-NCT co-
crystal was achieved using DSC Q2000 (TA Instruments, Crawley, West
Sussex, UK). Instrumental calibration in relation to the enthalpy and melt-
ing temperature were performed on indium, while the heat capacity was
calibrated against sapphire.
In the current work, samples of 3 to 4 mg were encapsulated in non-
hermetic aluminium T-zero pans. A standard DSC method was adopted,
in which samples were heated from 20 °C until 150 °C at a heating rate of
1 °C/min. They were afterwards allowed to cool at room temperature for
24 hours before being reheated again at similar rate. In addition to that, a
thermal DSC scanning starting from -35 °C until 150 °C at a heating rate
of 1 °C/min was also performed on FBP:NCT melted sample quenched at
-35 °C.
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Moreover, a modulated DSC method was employed whereas temper-
ature points were oscillated at an amplitude of ± 0.5 °C each 40 sec and the
underlying heating rate was set at 1 °C/min. Melted samples were allowed
to cool slowly to RT before they were reheated starting from 20 °C until
150 °C.
A series of 13 physical mixed samples of FBP:NCT were used for
phase diagram construction. Mixtures were prepared at diﬀerent mixing
molar ratios (0, 112 ,
1
6 ,
1
4 ,
1
3 ,
5
12 ,
1
2 ,
7
12 ,
1
3 ,
3
4 ,
5
6 ,
11
12 , 1) and screened using DSC.
Mixture samples were melted and then allowed to cool at RT for 24 hours after
which heating ramps were conducted as previously mentioned in the standard
DSC method starting from 20 to 150 °C at a heating rate of 1 °C/min.
HSM Studies:
Thermoscopic investigation on FBP-NCT co-crystal was also observed using Pri-
orLuxMET optical polarised hot-stage microscope (PriorLuxMET, Prior Scien-
tiﬁc, Fulbourn, Cambridge, UK), equipped with a Linkam DSC600 heating
freezing stage. The latter is controlled by T95-Linksys temperature programmer
and Linksys32 software (Linkam Scientiﬁc Instruments Ltd., Tadworth, UK).
FBP-NCT samples were focused through magniﬁcations 4× and 10×. Mi-
croscopic images were collected, through CCD camera attached to the microscope,
each 2 sec time intervals, using image capture software which is built within
Linksys32 package. Thermal scanning proﬁle was set to heat quenched melted
1:1, FBP:NCT over a temperature range of 20 → 130 °C at a 1 °C/min heating
rate.
4.3.2 Raman Spectroscopic Screening
A LabRAM HR from HORIBA Jobin Yvon (Villeneuve d'Ascq, France) was ex-
ploited to collect Raman spectra from the starting materials and co-crystal prepa-
rations. Samples were illuminated using diode-pumped solid-state (DPSS) laser
at 532 nm. They were scanned over a spectral range of 20  3500 cm-1. Raman
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spectra were acquired through an objective of 50× magniﬁcation based on an
acquisition time of 4 sec per spectrum. Signals were dispersed through grating
600 lines/mm and detected by CCD detector. The Raman system was calibrated
before acquiring measurements on a standard silicon (Si) sample after adjusting
spectrograph zero position. Raman data were acquired and analysed through
LabSpec 5 software.
The LabRAM HR is also supplemented with a XY manual cooling/heating
stage (Linkam LTS350) with TMS94 temperature controlling programmer and
LNP94 cooling system. These accessories were provided by Linkam Scientiﬁc
Instruments Ltd (Surrey, UK) and allow for the use of variable temperature (VT)-
Raman experiment. VT-Raman experiment was performed on a melted equimolar
physical mixture of FBP-NCT. Spectra were collected each 1 °C while heating the
sample at a rate of 1 °C/min from -40→ 150 °C. Raman spectra were also acquired
through a 50× objective but with an acquisition time of 2 sec/spectrum. Laser
focusing was achieved by optimising the intensity of peaks over a range of 1500 -
1600 cm-1. The resulting VT-Raman data were analysed by means of PCA using
separate free package designed by the R Foundation for Statistical Computing, R
version 2.15.0.
4.3.3 X-ray Diﬀraction Screening
A Bruker D8 Advance powder diﬀractometer (Bruker AXS LTD., Coventry, UK)
was utilised to collect powder patterns in a Debye-Scherrer geometry. X-ray radi-
ation was generated inside a ceramic X-ray tube from an anode made of copper Cu
in Kα1 spectral line at wavelength λ=1.54059 Å. The diﬀractometer is equipped
with a scintillation detector and Bruker Kristalloﬂex generator set on a voltage
of 40 kV and a current of 40 mA. Samples were loaded in borosilicate glass capil-
lary tubes BGCT with 0.7 mm bore diameters, supplied by CTS Capillary Tube
Supplies Ltd UK, and mounted on the goniometer in a preferred orientation.
Samples were scanned within 2θ (5 to 45°) at a 0.25 sec/step speed in an incre-
ment of 0.0179°. DIFFRACplus software package version 2.3 was used for data
acquisition.
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The Bruker D8 Advance is provided with a heating-cooling system Cryo-
stream Plus. (Oxford Cryosystems Ltd., Long Hanborough, Oxford, UK), con-
trolled by a Cryopad PC programme for the use of variable temperature x-ray
powder diﬀraction (VT-XRPD) scans. VT-XRPD scans were set as previously
mentioned, whereas samples were scanned within 2θ from 5 to 45° at a 0.25
sec/step speed in an increment of 0.0179°, and patterns were acquired each 3 °C
from heated samples at a rate of 1 °C/min within the range of 20 → 130 °C.
Single X-ray structure determination:
Single crystals suitable for X-ray structure determination were achieved from sol-
vent screening experiment, where 50 mg of liquid assisted ground FBP-NCT co-
crystals were dissolved in 3 ml of acetonitrile (ACN) and left for slow evaporation.
A suitable crystal was mounted on Bruker Nonius Smart Apex CCD diﬀractome-
ter (Bruker AXS LTD., Coventry, UK). X-ray radiation was generated inside a
ceramic x-ray tube from an anode made of Mo in Kα spectral line at wavelength
λ=0.71073 Å. The diﬀractometer is equipped with a Bruker Kristalloﬂex genera-
tor set on a voltage of 50 kV and a current of 40 mA, a graphite monochromator,
and an Oxford Cryosystem Cryostream (Oxford Cryosystems Ltd., Long Han-
borough, Oxford, UK). SMART software was used for collecting frames, indexing
reﬂections, and determining lattice parameters. SAINT programme was used for
integration of reﬂections intensity and scaling. Absorption correction was done
in SADABS programme, and SHELXTL software was used for space group de-
termination, structure solution, and least-squares reﬁnements. Structures were
solved by direct methods, and non-hydrogen atoms were reﬁned anisotropically.
Hydrogen atoms of O−H group were reﬁned from diﬀerence fourier maps. Other
hydrogen atoms C−H were generated geometrically and allowed to ride on the
bound heavy atoms167.
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4.4 Results and Discussion
Koﬂer preparation of FBP-NCT model system previously screened using Raman
mapping technique, showed the formation of co-crystal at the zone of mixing. This
was conﬁrmed to be optically and chemically diﬀerent from parent components
(FBP and NCT) (ﬁg B.1)168. On a prolonged storage at ambient condition,
a morphological change in the compound along the middle region was observed;
more speciﬁcally another phase formed gradually along this region (ﬁg 4.2).
  NCT
FBP
co-crystal 
phase I
co-crystal 
phase II
5.0 µm
Figure 4.2: Hot-stage microscopic image of FBP-NCT Koﬂer preparation after
a time of storage. Koﬂer preparation, which originally includes NCT (left) and
FBP (right) and the zone of mixing in between (spherulites of co-crystal phase
I), showed after a prolonged time of storage another phase (co-crystal phase II)
gradually growing in a bottom-top manner along the zone of mixing.
Following such observation, Raman mapping of this preparation was con-
ducted in order to generate a detailed information about formed phases along the
zone of mixing. The resulting Raman data were analysed using DCLS analysis∗
when n=5 (ﬁg 4.3 a). The analysis showed ﬁve regions in this preparation corre-
∗Similar analysis was performed on FBP-NCT Koﬂer preparation (chap 3) which
revealed a distinct distribution of three components within the preparation (FBP, co-
crystal, and NCT).
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sponding to NCT (left-handed side, green), both FBP forms (I & II) (right-handed
side, purple and yellow, respectively), and another region running vertically up the
zone of mixing (blue) in addition to co-crystal form I (red). Single Raman spec-
tra were acquired from both morphologically diﬀerent regions along the zone of
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Figure 4.3: Raman spectroscopic analysis of FBP-NCT Koﬂer preparation over-
time of storage using DCLS method (a). The analysis showed the distribution of
NCT (green), FBP form I (purple), FBP form II (yellow), and co-crystal form
I&II in (red and blue, respectively). The image is accompanied by single Raman
spectra acquired from two morphological diﬀerent regions in the zone of mixing
(b); co-crystal form I (red) and co-crystal form II (blue).
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mixing (ﬁg 4.3 b). Both spectra conﬁrmed their comparability in the molecular
vibrational region but not in the intra-molecular phonon region, which indicated
to the likelihood of having polymorphic forms of FBP-NCT co-crystal.
Therefore, the study along the course of this chapter was carried out to in-
vestigate the potential of having FBP-NCT co-crystal of diﬀerent crystalline struc-
tures. However, before subjecting FBP-NCT co-crystal to polymorphic screening
study, a sensible discussion regarding the stoichiometric ratio of interactions be-
tween parent components (FBP and NCT) is worth mentioning. Despite the
fact that it is diﬃcult to predict the accurate interaction between synthons, one
can estimate the possibility of various interaction between moieties based on the
information stored in CSD169.
From a supramolecular perspective under the crystal engineering proto-
cols for co-crystal formation45, the interaction between the starting components
of co-crystals is facilitated by their complementary functional groups44,170. In
FBP:NCT case, NCT molecule has got two potential hydrogen-bonding sites
(pyridyl and amide groups), while FBP has got one site (carboxylic acid group).
Flurbiprofen
- COOH
Nicotinamide
- CONH2
- N pyridine
+
Flurbiprofen
- COOH
Nicotinamide
- CONH2
- N pyridine
1:1 FBP-NCT co-crystal 
acid-pyridine synthon
Flurbiprofen
- COOH
Nicotinamide
- CONH2
- N pyridine
1:1 FBP-NCT co-crystal 
acid-amide synthon
Figure 4.4: Schematic of possible interaction between co-crystal parent compo-
nents. The structures of supramolecular synthons of FBP-NCT co-crystals with
1:1 stoichiometric ratios were expected to be held; via acid-pyridine interaction
(a), or via acid-amide interaction (b).
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The presence of such groups might lead to the formation of two molecular com-
plexes; acid-pyridine FBP-NCT or acid-amide FBP-NCT synthons which in either
way can lead to the forming of FBP-NCT co-crystals of 1:1 (ﬁg 4.4). This can
also lead the formation of co-crystal at 2:1 molar ratio if both synthons share in
holding the interaction between FBP and NCT (ﬁg B.2). Therefore, the possi-
bility of getting diﬀerent synthons of FBP-NCT co-crystals interacting into two
molecular ratios (1:1 or 2:1) exist.
4.4.1 Classical Thermal Studies
DSC Study of FBP-NCT Binary Phase Diagram:
In order to investigate the assumption regarding the stoichiometric ratio of inter-
action, the binary phase diagram of FBP-NCT was constructed based on fusion
method. Starting from the parent components, 13 physical mixtures of both NCT
and FBP mixed at diﬀerent stoichiometric ratios (0, 112 ,
1
6 ,
1
4 ,
1
3 ,
5
12 ,
1
2 ,
7
12 ,
1
3 ,
3
4 ,
5
6 ,
11
12 , 1), were fused using DSC technique. The changes in the properties of
FBP:NCT mixtures as a function of temperature were observed from their ﬁrst
DSC thermal traces which were looked at in order to extract the melting tempera-
tures of corresponding mixtures. Both sets of temperatures (melting temperatures
extracted from 2nd DSC scans) were plotted against the molecular ratio of NCT
(ﬁg 4.5).
The basic feature in phase diagram should show a decrease in the melting
points of either components when both components co-exist as a mixture. This
decrease in temperatures last until both components eventually meet at the lowest
temperature forming the eutectic mixture. If the latter mixture, which is formed
at a speciﬁc ratio of mixing, is capable of recrystallisation in a co-crystal phase,
then such formation leads to a humped-shape curve emerging from between the
melting curves of the starting materials. This new curve refer to the melting points
of the new compound (molecular complexes) in the presence of melted mixtures of
the starting material at diﬀerent compositions42,109. It is apparent based on that
to realise that the formation of FBP-NCT co-crystals from the melt occurs at an
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Figure 4.5: Binary phase diagram of FBP-NCT. It shows the potential formation
of co-crystal at a ratio of 1:1 (50%), whereas the melting temperatures were
extracted from the second DSC scans of melting both FBP and NCT at diﬀerent
molecular ratios.
equimolar ratio of the starting materials only (ﬁg 4.5, arrow). Therefore, the
chance of having co-crystal at 2:1 molar ratio of FBP-NCT was excluded and the
emphasis was rather to tackle the presence of co-crystal polymorph at 1:1 molar
ratio.∗
DSC Polymorphic Study of 1:1, FBP-NCT Co-crystal:
Based on the constructed binary phase diagram of FBP:NCT (ﬁg 4.5), only
the equimolar physical mixture of FBP and NCT was taken forward for further
polymorphism investigation. So to start with, FBP-NCT co-crystal was formed
by fusing both FBP and NCT at an equimolar ratio of mixing. The ﬁrst thermal
scanning of both FBP and NCT, 1:1 using standard DSC procedure is shown in
ﬁg 4.6 a. DSC trace showed two endothermic events; a major one occurred at
97.10 °C, preceded by a small trace of another endothermal event at 89.45 °C (ﬁg
∗The polymorphism of FBP can complicate the shape of the binary phase diagram
of FBP:NCT and mislead the judgements about the right ratio of co-crystal formation
using fusion method. For instance, a small portion of phase diagram on left-handed side
of ﬁg 4.5 indicated falsely to co-crystal formation at a ratio of 6:1, FBP:NCT, which is
not typical when looking at the structure of FBP and NCT.
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Figure 4.6: DSC scans of 1:1 FBP-NCT physical mixtures. It shows two en-
dothermic events at 89.45 °C and 97.10 °C in (a). Re-heating scan of previously
melted FBP:NCT mixture exhibited two exothermic events; one at 47.76 °C and
another complex event at (57 to 66 °C), followed by a sharp melting at 95.57 °C
as shown in (b).
4.6 a). These melting events were varied from the melting points of the starting
materials; 128.17 °C and 113.55 °C of NCT and FBP, respectively (ﬁg B.3).
Thermal re-scanning of 1:1 melted FBP:NCT, which was allowed to cool
slowly to RT, was performed to check the reliability of previous observations.
The resulting trace (ﬁg 4.6, b) showed this time a shallow exothermic one at
about 47.76 °C most likely referring to crystallisation event, followed by another
complex exothermic event at 66.33 °C, ended by a melting at 95.57 °C.∗ From the
standard DSC procedure, melted FBP-NCT displayed two crystallisation events
and one melt.
∗The thermal behaviour of 1:1 melted FBP:NCT compound was reproducible when
the melted compound was scanned for the third time.
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A modulated DSC scanning was run to deconvolute the complexity of crys-
tallisation and separate underlying events at 66.33 °C (ﬁg B.4). This technique
provides additional information to standard DSC methods. MDSC heat ﬂow can
be separated into two traces; the ﬁrst signal refers to thermodynamic compound
(reverse heat ﬂow), alternatively the second signal indicates the kinetic product
(non-reverse heat ﬂow trace). MDSC trace of 1:1 melted FBP:NCT (ﬁg B.4)
displayed two crystallisation events on the nonreverse heat ﬂow trace (a simple
crystallisation event at 47.02 °C and another complex one at 66.94 °C), so this
added no further information to the standard DSC outcomes. On the other hand,
the information on the reverse heat ﬂow trace gave some clue to the thermal event
at 66.94 °C. It revealed a preceding endothermal event at 59.81 °C. This event
alerted for considering the presence of another product which co-exists with the
main compound. Such assumption can be quite sensible especially when recalling
the observation along the zone of mixing in the RT-stored Koﬂer preparation (ﬁg
4.2).
To rationalise the statement of having co-existence phases of FBP-NCT
(a kinetic and thermodynamic products), a decision was made to restrict the
degree of freedom within fused FBP-NCT system by applying Ostwald's rule of
step changes171173. This can be obtained by entrapping the molecules of melted
compound into their glassy state then allowing for successive crystallisation of
potential phases via slow heating.
Thereupon, the start point should be from the glassy state of material.
This phase was achieved by rapidly cooling corresponding melted compound or
what so called sample quenching process. Based on that, a quenched melted
FBP:NCT, 1:1 mixture was held at -35 °C, followed by a slow heating by means
of DSC until the melting occurred.
The thermal DSC trace of rapidly cooled sample is displayed in ﬁg 4.7. It
revealed the glass transition at -0.13 °C, it also showed a crystallisation at 54.53
°C, followed by a consecutive thermal events encompassing both endothermic and
exothermic peaks at 73.16 °C and 75.03 °C respectively, ended by a melt at 96.58
°C. Consequently, six phases appeared on heating quenched melted 1:1, FBP:NCT
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compound; glassy state 7−→ supercooled liquid 7−→ crystallisation of solid phase I
7−→ melt I 7−→ recrystallisation of solid phase II 7−→ ﬁnal melt II. DSC outcomes
revealed that the solid phase I underwent an instantaneous rearrangement process
once melted (73.16 °C), which has been replaced by another phase at 75.03 °C. The
ﬁrst metastable phase is thought to be the kinetic product, which its presence was
diﬃcult to recognise at the beginning of the research work until using quenched
method of fusion. The second phase is the more energetically favoured form
(the most stable form), and its presence was not much aﬀected when changing
the method of sample preparation. Overall, changing the method of thermal
scanning enabled to distinguish between the kinetic and thermodynamic solid
forms in FBP-NCT system. Thereafter, this method of sample preparation was
adopted for the following co-crystal polymorphic studies.
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Figure 4.7: Quenched melted 1:1 FBP-NCT mixtures were screened using DSC.
The ﬁgure displays DSC trace while heating the resulting compounds. Thermal
scans were performed over a range of (-35 to 135 °C), which revealed the following
events: glass transition (Tg) at -0.13 °C, crystallisation of co-crystal form I (CC
I) at 54.53 °C, followed by simultaneous events of (CC I) melting and recrystalli-
sation of co-crystal form II (CC II) at 73.16 °C and 75.03 °C, respectively, ﬁnally
the melt of (CC II) at 96.58 °C.
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HSM Study of 1:1, FBP-NCT Co-crystal:
Earlier thermal DSC observations (ﬁg 4.7) were optically explored by means of
HSM. This optical tool is quite helpful in understanding the solid-state forms of
materials. The combination between microscopic and thermal scanning provides
information about the physical changes of materials over heating process. In
another word, the physical characterisation as a function of temperature and
time can be achieved using such tool.
Thereupon, a sample of quenched melted FBP:NCT, 1:1 was explored by
HSM. The resulting photomicroscopic images, snapshot at various temperatures,
were selected to show the consecutive transformation events (ﬁg 4.8), which
encompassed a series of events;
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Figure 4.8: Photomicroscopic of melted 1:1 FBP-NCT at various temperatures
in the hot-stage microscope experiment. It shows the crystallisation of form I in
ﬁrst row of images, followed by the formation of concomitant forms (the melting
of form I and the simultaneous crystallisation of form II) in the second row, ﬁnally
the melting of form II in the third row.
 The crystallisation of phase I: the nucleation of starlike crystals, from
amorphous phase (20 °C), occurred at 42.5 °C. The growth of this solid
phase became more obvious at 55.4 °C (ﬁg 4.8, 1st row).
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 The simultaneous melt and re-crystalisation: A careful inspection on
ﬁrst crystallisation, revealed the emergence of small needled crystals from
the surrounding parts of starlike crystals, resulting in crystals of a stellar
dendrite shape at 62.1 °C. Subsequently at a temperature range of 71.2 °C
to 74.2 °C, the melt of stellarlike crystal and the simultaneous crystallisation
of needled crystals were noticed (ﬁg 4.8, 2nd row).
 Phase II and its melt: The growth of needled crystals occurred at the
expense of the starlike crystals which became merely of needled shape above
77.0 °C, and then it started to melt at 95.6 °C (ﬁg 4.8, 3rd row).
Thus, the optical images referred to the following thermal events; amorphous
material → solid form I → solid form II → ﬁnal melt, and such ﬁndings tie in
nicely with previous DSC ﬁndings. Although, the interpretation of DSC and
HSM outcomes could be indicative to the formation of concomitant phases, which
with the increase of time resolved one phase from the other, yet they can not be
deﬁnitive. This is because all these observations depend on the physical changes
occurred during thermal transitions. Therefore, more investigation was required
to unambiguously identify the type of present phases. Studies which probe the
intermolecular interactions between FBP and NCT and the crystalline structure
of resulting compound, were believed to be essential in polymorphism character-
isation; i.e. the use of Raman spectroscopic and x-ray diﬀraction techniques.
4.4.2 Raman & Diﬀraction Studies vs Heat & Time
Further investigation was conducted by combining similar thermal approaches
with spectroscopic and x-ray diﬀraction techniques. Such strategies are helpful in
providing detailed information about the molecular and the crystalline changes
while subjecting samples to consecutive heating environment. Again, the main
theme of exposing quenched sample to successive heating conditions during Ra-
man and diﬀraction studies, was to satisfy Ostwald's rule174. This rule states
that any attempt to crystallise material leads over timescale to the formation of
metastable polymorph before isolating the most stable form171173.
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VT-Raman Studies of Quenched Melted 1:1, FBP:NCT
Considering the VT-Raman data ﬁrst, Raman spectra which were collected as a
function of temperature over a heating range of -40 to 150 °C from a quenched
melted 1:1, FBP-NCT sample, are presented in ﬁg 4.9 and spectra are colour
coded in red each 10 °C for the ease of data presentation.
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Figure 4.9: VT-Raman raw data of quenched FBP:NCT sample. Spectra are
stacked in a bottom-top manner starting from the spectrum collected at -40 °C
ended by the one acquired at 150°C. Spectra are mostly colour coded in black
apart from those obtained each 10 °C which are colour coded in red for the ease
of data showing. The intensity of data are oﬀset and median ﬁltered to get rid of
the spikes.
Raman data appeared to be diﬃcult to interpret from the instant visual
inspection in ﬁg 4.9. Thereafter, the presentation of Raman data was changed
using colour contour plot (ﬁg 4.10 a).∗ Raman data, which consist of three sets
of variables (temperatures, Raman intensities, and Raman shift), were simpli-
ﬁed by horizontally plotting the intensity of each Raman spectrum as a function
∗ Phonon data were decided to be explained about in the main body of this the-
sis134,175, yet the presentation of VT-Raman data in diﬀerent wavenumber regions is
available in ﬁg B.5.
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of temperature. The x-axis refers to Raman shift, colours on Z-bar represent
scaled Raman intensities, and y-axis refers to temperature points (ﬁg 4.10 a).
The resulting plot, currently appears into a 2D form, revealed some noticeable
wavenumber bands which were distinct over certain temperature ranges. These
bands were correlated with diﬀerent phases formed over heating process as clearly
noticed in ﬁg 4.10 a. Despite such apparent transformation between solid-state
materials, identifying these phases can not be accurately deduced by eye; and
hence the distinction between diﬀerent spectra of various solid-state forms is not
quite straightforward by visual inspection.
To further explore these phases, data were subjected to an automated
analysis. PCA was employed to resolve accurately the spectra and the temper-
atures at which phases were formed without any potential interference. PCA
outcomes herein were almost explained based on their scores.
Scores were ﬁrstly studied against the changes of temperature. The ﬁrst
three PCs were plotted over a thermal range of -40 → 150 °C in ﬁg 4.10 b.
Investigation within the range of -40 → 25 °C, revealed steady changes in the
scores as a function of temperature (ﬁg 4.10 b). Nonetheless, the gradual pro-
cess of transformation over this range of temperature was not continuous and it
was rather separated by a barrier point. This points represents the boundary
between the brittle glassy state and viscous state. The temperature at which
the transformation between the glassy state and supercooled liquid took place is
called the glass transition temperature (Tg). Tg is highly inﬂuenced by the ther-
mal history of cooled melted sample, speciﬁcally the inner state of amorphous
phase and its dynamic aggregation state, which generally lead to a less suddenly
changes between glassy state and supercooled liquid state as noticed in ﬁg 4.10
b. According to VT-Raman data, the small step of change in the scores between
the glassy state and viscous state occurred at about -4 °C (ﬁg 4.10 b). When
recalling DSC outcomes (ﬁg 4.7), one can realise that Tg can also be deduced,
however the occurrence of this event was slightly higher (-0.13 °C). Such varia-
tion is quite acceptable when taking into consideration the timelag in recording
measurements, and the thermal sensitively of used instruments.
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Figure 4.10: VT-Raman analysis of quenched melted FBP:NCT system. Firstly,
a 2D plot of VT-Raman data of quenched melted 1:1 FBP-NCT mixtures is shown
in (a), whereas the x-axis represents the temperature (°C), y-axis is Raman shift
(cm-1), and colours indicate to scaled Raman intensity. Secondly, PCA analysis
was performed on VT-Raman data, and in (b) is the resulting PCs scores of the
ﬁrst three PCs as a function of temperature.
The following transition event occurred at about 30 °C which referred
to the crystallisation of co-crystal form I. The formation was initiated once the
viscous state began to exhibit some molecular kinetic changes represented by
a reduction in the free molecular motion of particles, and this was manifested
into a sudden change in PCs scores at about 30 °C (ﬁg 4.10 b). The successive
formation of such particles led to secondary nuclei and so on until achieving nuclei
of suitable size for crystalisation. This resulted in some ﬂuctuations in PC's scores
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over a small range of temperature (31 → 37 °C), followed by a steady increase in
PCs scores until the formation of co-crystal form I became more prominent (50
→ 74 °C).∗
The formation of co-crystal form I was followed by the formation of another
phase, and this was alluded from the sudden change in the scores at about 77 °C
(ﬁg 4.10 b). This abrupt change most likely referred to the transformation to
another co-crystal form II before melting occurred at about 100 °C (ﬁg 4.10 b).
Solid-solid transformation between both co-crystal forms was indicated to
from the scores of PC2 & PC3 but not from those of PC1. PC1, which repre-
sents the majority of data variability (64.12%), showed instead a transition at a
preceding temperature (at about 75 °C). Such variability in the scores' behaviour
over temperature range of (75 → 77 °C) might highlight the presence of previ-
ous thermal event occurring before solid-solid transformation (ﬁg 4.10 b). These
ﬁndings needed more clariﬁcation by studying the PCA scatter plot of VT-Raman
data.
Accordingly, the scatter plot of PC1 and PC2 scores was studied as a func-
tion of each other (ﬁg 4.11). This is useful in the phase transformation analysis,
because the co-ordinate sets (PCs) are deﬁned in terms of the variance of the
data, with the ﬁrst axis (PC1) having the most variance (64.12%) and the second
axis (PC2) having the second most of data variation (19.70%). Since diﬀerent
solid-state phases can be distinguished due to their variations in the properties
(i.e., the physical properties), including the scores plot can reveal these varia-
tions. More speciﬁcally herein, it can further clarify and ascertain the behaviour
of distinct groups (solid-state phases) which cluster separately over heat and time
parameters. Overall, the scatter plot can pinpoint the order of phases with their
exact temperature of formation.
Thereupon, the scores' plot (scatter plot) of the ﬁrst two PCs, generated
from the VT-Raman data, is shown in ﬁg 4.11 a. Few observations were noticed
∗ The scenario of achieving some localised co-crystal form I particles followed by the
growth of other nuclei among amorphous region caused some topographical changes in
the area from which spectra were collected. Raman spectra extracted over temperature
range of 31 → 74 °C (ﬁg B.6), supported earlier interpretation regarding the scores of
CC I group. These spectra showed a clear formation of CC I after 50 °C (ﬁg B.6, blue).
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when looking at the resulting scatter plot (ﬁg 4.11 a);
 There are two well separated clusters from the scatter plot over a temper-
ature range of -40 → 30 °C, although they chemically appeared to be of an
amorphous state. Both groups are indicated to as a group (1) in ﬁg 4.11 a,
"black" and group (2) in ﬁg 4.11 a, "maroon", and their Raman spectra
are presented in 4.11 b. The separation, which occurred at -6 °C, referred
to a glass transition temperature, and this was also conﬁrmed from PCA
outcomes as a function of temperature (ﬁg 4.10 b) and DSC trace pre-
sented in ﬁg 4.7. Therefore, both groups observed from PCA scatter plot
are correlated with a glassy state (group 1) and supercooled liquid state
(group 2) of FBP:NCT system, and the transition between both phases
occurred at a Tg of -6 °C.
 The third group (3) was noticed from the cluster over a temperature range
of 31 → 74 °C (ﬁg 4.11 a, "red"), and it is related to co-crystal form I
(ﬁg 4.11 b). The scores of CC I do not exhibit a very tight cluster until
about 50 °C. This was believed due to the ongoing crystallisation process
from amorphous, and this agrees nicely with the tailed trend of CC I scores
as a function of temperature (ﬁg 4.10 b).
 Interestingly, the remaining two clusters were noticed over inconsecutive
ranges of temperature. The ﬁrst cluster encompassed two temperature
ranges; one over 75 → 77 °C (ﬁg 4.11 a, "purple") & another one over
99→ 120 °C (ﬁg 4.11 a, "green"). The second cluster appeared over one
temperature range (78 → 98 °C) (ﬁg 4.11 a, "blue").
 Having two groups classiﬁed in one cluster, 75→ 77 °C (ﬁg 4.11 a, "pur-
ple") & 99→ 120 °C (ﬁg 4.11 a, "green"), might refer to two solid-state
groups of comparable chemical features. Consequently, Raman spectra were
extracted from temperatures where both groups are classiﬁed together (ﬁg
4.11 b). Raman spectral comparison in ﬁg 4.11 b revealed that the spec-
trum acquired at 75 °C looks fairly comparable to the spectrum collected
at 99 °C and they both refer to the melt of phases.
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Figure 4.11: VT-Raman data of quenched melted FBP-NCT sample. It shows
in (a) the scatter plot of PC1 (64.12%) vs PC2 (19.70%). Group of clusters are
indicated to by colours and they refer to FBP:NCT glassy state "group 1, black",
supercooled liquid "group 2, maroon", CC I "group 3, red", the melt of CC I
"group 4, purple", CC II "group 5, blue", and ﬁnally the melt of CC II "group
6, green". Corresponding Raman spectra are shown in (b), and they arranged in
a bottom-top manner starting from glassy state, supercooled liquid, CC I, CC I
melt, CC II, and CC II melt. Spectra are displayed into two regions (phonon and
molecular regions).
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 Now examining the cluster appeared over a temperature range of 78 → 98
°C (ﬁg 4.11 a, "blue"), showed that this solid-state group refer to the
formation of CC II (ﬁg 4.11 b). Hence, the formation of CC II started
from 78 °C and not 75 °C. Surprisingly, the appearance of CC II does not
arise following the crystallisation of CC I group (3) as was assumed from ﬁg
4.10 b. This means that the preceding group over a temperature range of
75→ 77 °C which has got the feature of the melt (ﬁg 4.11 b) and becomes
group (4), refers to the melt of CC I before the recrystallisation in another
phase (CC II) group (5). Based on that, the cluster of the ﬁnal group (6)
appeared over a temperature range of 99 → 120 °C (ﬁg 4.11 a, "green")
and has got the feature of the melt, is related to the melt of CC II.
Overall, the type of group clustering (ﬁg 4.11 a) and their representative Raman
spectra (ﬁg 4.11 b), conﬁrmed that these groups are related to the glassy state
(-40 → -5 °C) 7−→ supercooled liquid (-6 → 30 °C ) 7−→ co-crystal form I (CC I)
(31 → 74 °C) 7−→ CC I melt (75 → 77 °C ) 7−→ co-crystal form II (CC II) (78 →
98 °C) 7−→ CC II melt (99 → 120 °C).∗
Recalling consecutive thermal events from the DSC trace ﬁg 4.7, and
the images obtained from the HSM (ﬁg 4.8), indicated that the melt of CC I
was also observed from the VT-Raman experiment. So what was observed from
the diﬀerent behaviour of PC1 as a function of temperature at about 75 °C (ﬁg
4.10 b) was an indication to the successful separation between CC I and CC
II, and a conﬁrmation that CC II formation does not emerge from a structural
rearrangement within CC I compound but rather appeared from a melted FBP-
NCT (CC I) phase. A comparable picture occurred to CC I which crystallised
from an amorphous state of FBP:NCT (supercooled liquid state).
Correlating Raman outcomes with the HSM and DSC results revealed
some slight variability in the occurrence of events. While the onset of transfor-
mation events are slightly diﬀerent, the trend of solid-state transitions according
∗The comparison between Raman spectra extracted at 55 and 77 °C, and Raman
spectra acquired from FBP and NCT as received, conﬁrmed that these both phases are
new compounds (CC I & CC II, respectively) (ﬁg B.7).
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to spectroscopic data is similar to those deducted from the HSM and DSC. Such
diﬀerences in transition temperature resulted from the variation in detection level
of chosen technique. For instance, DSC and HSM are considered as bulk analysing
techniques while backscattering Raman spectroscopy was used in its single-point
screening mode. Besides, the allowance time in VT-Raman experiment compared
to HSM and DSC brings earlier observation for the occurrence of thermal events.
During VT-Raman experiment, Raman spectra were not acquired constantly over
heating process but rather there was a holding time at each temperature degree
and this allowed events to occur earlier than expected. There was also a delay
occurring after each spectral collection due to the movement of the grating to
zero-position, and an autofocus setup which was employed to ensure having the
most intense spectrum at each single point. Thereby, such technical issues could
oﬀer the molecules of FBP-NCT co-crystal a suﬃcient time to relax at a lower
temperatures in comparable to traditional thermal methods (DSC and HSM). In
general, there was a good correlation between HSM & DSC inspection and VT-
Raman results. All techniques indicated to phase state transitions corresponded
respectively to the crystallisation from amorphous material into co-crystal form I
initially before the formation of co-crystal form II.
VT-XRPD Studies of Quenched Melted 1:1, FBP:NCT
XRD is a gold-standard technique in the chemical characterization of unknown
materials, and the crystalline determination of their phases. It was employed
in such type of work to further identify the crystalline states of FBP-NCT co-
crystal materials formed over heating process, and more speciﬁcally to verify the
polymorphic forms of FBP-NCT system.
This was aimed to be achieved by collecting the x-ray powder patterns
from quenched melted 1:1, FBP-NCT sample as a function of temperature. Again,
PCA was utilised to analyse variable temperature data of x-ray powder patterns.
VT-XRPD data and the outcomes of PCA analysis are displayed in ﬁg 4.12.
VT-XRPD data were handled similarly as were VT-Raman data.
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Figure 4.12: VT-XRPD data analysis. (a) is a 2D plot of XRPD data whereas
x-axis is 2θ/°, y-axis is temperature, and colours represent scaled intensity. The
plot is coupled with a plot of PCs scores versus temperature (left-hand side), and
the loading plot of the ﬁrst two PCs (bottom). (b) shows XRPD patterns at the
transition temperatures; 20 °C, 47 °C, 68 °C, and 110 °C.
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Firstly, the VT-XRPD data are presented into a 2D form (ﬁg 4.12 a),
accompanied by PCA outcomes (PCs' scores as a function of temperature on the
left-handed side, and PCA loadings plot below). It is quite obvious by looking
at the contour plot and PCs score plot (ﬁg 4.12 a), to observe four phases
formed over heating process. This was not only checked by eye, but it was also
conﬁrmed from x-ray powder patterns collected from FBP:NCT state phases at
the transformation temperatures (ﬁg 4.12 b).
PCA outputs from VT-XRPD were in consistent with what was observed
earlier using diﬀerent techniques (Raman spectro), in terms of displaying both
FBP-NCT co-crystal forms (ﬁg B.8). However, the number of all presence phases
in FBP-NCT system and the onset of thermal events from VT-XRPD varied, and
in summary the current XRPD study showed that;
 The initial crystallisation and the ﬁnal melting started at diﬀerent temper-
atures from those observed in VT-Raman experiment; 47 °C and 110 °C
(VT-XRPD, ﬁg 4.12) versus 31 °C and 98 °C (Raman data, ﬁg 4.10),
respectively.
 The solid/solid transformation occurred in an instantaneous manner with-
out passing through the melt of co-crystal form I. CC I recrystallised in
another form CC II, and this happened at 68 °C (ﬁg 4.12).
Such variation in transition temperatures, despite method similarity of sample
preparation, could be due to the inequality in the heating environment around
the entire sample within the diﬀractometer. Only the pointed part of the capillary
tube was subjected to the heating source, and thus more time should be oﬀered for
the sample per temperature degree before the x-ray powder pattern was collected.
However, since the main interest was the polymorphism aspect within
FBP-NCT co-crystal system, VT-XPRD outcomes were quite adequate for the
comparison purposes between CC I and C II, and the starting components (FBP
and NCT) (ﬁg B.9). This comparison showed that not only both forms look
diﬀerent from each other, but they are also diﬀerent from the starting materials.
Thereupon, solid phase appeared from FBP:NCT system are related to diﬀerent
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polymorphic forms of FBP-NCT, and the question left to answer was what is the
identify of the crystal structure of FBP-NCT co-crystal.
4.4.3 FBP-NCT Single Crystal X-ray Pattern
The single crystal x-ray diﬀraction experiment was conducted to identify the
crystal structure of co-crystal and to ﬁnd its relationship with collected powder
patterns from the solid-state phases of quenched melted 1:1, FBP:NCT system
(ﬁg 4.12).
The crystal structure and the x-ray pattern of 1:1 FBP-NCT co-crystal
were conﬁrmed from the single crystal x-ray reﬁnements of the experimental x-ray
data. Data were collected from single crystals of liquid-assistant ground FBP:NCT
(1:1) grew in ACN solution. The reliability factor (RWork) between experimental
diﬀraction pattern and the crystallographic model of FBP:NCT was equal to
9.72%. The crystal structure of FBP-NCT co-crystal is of a monoclinic lattice
system with a space group P21/c, and a unit cell of four FBP-NCT molecules Z=4
(ﬁg B.10). The parameters of each unit cell are as the following; cell lengths
are a=27.473(6) Å, b=5.6443(12) Å, c=11.432(3) Å, cell angles are α=90.00/°,
β=92.376(4)/°, γ=90.00/°, and cell volume is V=1771.19 Å3. The calculations
showed, as suggested (ﬁg 4.4), that co-crystal formation is mediated by acid--
pyridine heterosynthon (ﬁg 4.13). The chains adopt a zigzag shape supported by
NCT amide-amide dimer, and they stack parallel to the crystallographic b-axis
(ﬁg B.11).
The x-ray powder pattern was also built, following the calculations of
single crystal structure of FBP-NCT co-crystal. The resulting pattern was then
compared with the powder patterns of CC I and CC II extracted from VT-XRPD
experiment at 47 °C and 68 °C (ﬁg 4.14). It was found that the powder pattern
at 68 °C temperatures exhibited a good agreement with calculated pattern based
on single x-ray crystal experiment (ﬁg 4.14, blue vs black).∗ Such similar-
ity in x-ray patterns indicated that co-crystal II, which appeared from heating
∗ Calculated single x-ray pattern was slightly shifted towards the right because the
SXD experiment was performed at -180 °C.
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crystals viewed along crystallographic (a) direction. It shows the interaction be-
tween 1:1 FBP:NCT via acid-pyridine synthon and the mediation of NCT amide-
amide dimer to support the chains.
quenched melted 1:1, FBP:NCT over 68 °C, has similar crystal structure to the
one calculated from the single crystal of FBP-NCT. This means that CC II is 1:1
FBP-NCT co-crystal, whereas hydrogen bonds occur between carboxylic acid:N-
pyridine groups and the chains are sustained by NCT amide-amide homosynthons.
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On the other hand, it is quite noticeable by looking at the powder pattern
extracted from VT-XRPD at 47 °C, to observe its pattern diﬀerences from the
calculated pattern of FBP:NCT single crystal (ﬁg 4.14, red vs black). The
powder pattern at 47 °C also exhibited diﬀerent patterns from those of both of
the starting materials as mentioned earlier (ﬁg B.9). All of these ﬁndings conﬁrm
that such solid-state phase, is actually another form of FBP-NCT co-crystal (CC
I). ∗ †
4.5 Conclusions
FBP-NCT Koﬂer melt preparation over a time of storage indicated to polymor-
phism issue in the co-crystal along the zone of mixing. Therefore, a study was
conducted to probe the FBP-NCT solid state forms. The study entailed a proper
sample preparation followed by a polymorphic screening procedure. Polymorphic
screening involved using traditional thermal techniques (DSC and HSM), and
parametric measurement tools such as Raman spectroscopic and x-ray diﬀraction
as a function of time and temperature (VT-Raman & VT-XRPD).
The analysis revealed that all types of phase transformation; glass/viscous,
viscous/solid, solid/solid, and solid/liquid, can be clearly distinguished when
choosing the right preparation methodology, technique, and data analysis. For
instance, methods for producing FBP-NCT phases was optimised by adopting
protocol which complies with Ostwald's rule of step changes. Secondly, the use of
chemometrics (PCA) to analyse VT data i.e., VT-Raman data enabled to conﬁrm
a clear separation of phases from quenched melted 1,1 FBP:NCT; (-40 → -5 °C),
(-6 → 30 °C), (31 → 74 °C), (75 → 77 °C), (78 → 98 °C), and (99 → 120 °C);
referring respectively to glassy state, supercooled liquid, co-crystal form CC I, the
melt of CC I, co-crystal form CC II, ﬁnally the melt of CC II. PCA scores as a
∗Raman spectra extracted from VT-Raman data at 50 °C was also compared with
the spectra collected from FBP-NCT single crystal (ﬁg B.12).
†However, the crystal structure of CC I was not conﬁrmed due to the stability issue of
this form, yet XRPD and Raman are considered enough evidents for the characterisation
of two polymorphic forms of FBP-NCT co-crystal system.
Aalae Alkhalil 95
Chapter 4 The Study of FBP-NCT Co-crystal Polymorphism
function of temperature also conﬁrmed such successive transformations between
phases at -6 °C, 31 °C, 75 °C, 78 °C, and 99 °C.
Overall, the studies showed that amorphous phase underwent a gradual
relaxation over heating which was separated by Tg point. The following ordered
crystalline form (co-crystal form I) did not occur suddenly from amorphous phases
and this was most likely due to the nucleation and crystallisation process of co-
crystal form I at the beginning of transition temperature range (31→ 50 °C). The
solid-solid transformation between co-crystal from I & II did happen instantly
by rearrangement process, but it was rather mediated by the melt of form I and
recrystallisation of second form as was conﬁrmed from DSC and Raman outcomes.
Finally, the VT-XRPD conﬁrmed the presence of two polymorphic forms
of FBP-NCT co-crystal. The crystal structure of one of these forms was successful
identiﬁed and this was supported when the single crystal structure of FBP-NCT
co-crystal was calculated (SXD). Although FBP-NCT co-crystals achieved from
the fusion methods displayed a presence of transient phase (CC I) before forming
the stable form (CC II), such formation can be controlled using the right method
of sample preparation.
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CHAPTER 5
QC Probing of Model Co-crystal
Tablets by Transmission Raman
5.1 Abstract
The molecular complexes (co-crystals) were for the ﬁrst time formulated into phar-
maceutical solid form (tablets) using dry-press technique. The resulting tablets
were afterwards probed by transmission Raman spectroscopy (TRS). The work
presented in this chapter aimed at using pharmaceutical co-crystal in drug for-
mulation (tablets), driven by the fact that such type of molecular complexes are
designed to widen the scope of achieving the required physiochemical properties
of the APIs. This work was also motivated by the need to ﬁnd a good analytical
tool to screen pharmaceutical preparations; a procedure taken to comply with the
FDA call for the QC and good manufacturing processes (GMPs) within the ﬁeld
of pharmaceutical industry. The analytical screening was preceded by a proper
experimental design and complemented by choosing suitable statistical methods.
Mathematical analysis of TRS data revealed interesting information when com-
pared to the instant eye observation. Such ﬁndings were not only related to the
distinction based on the chemical contents of tablets (co-crystal vs physical mix-
tures), but also according to the ratio of drug contents (25% vs 50%) within the
pharmaceutical solid formulations.
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5.2 Introduction
Medications can be formulated in various ways according to the required route
of application, which is mostly aﬀected by the physicochemical properties of the
chosen drug. Drugs could be delivered in simple solutions, emulsions, suspensions,
etc, which with a certain level of sterility become suitable for parental injections
(internal application) or even ocular administration. Formulations can also be
designed for topical use (external application) which can be either aqueous, oily,
semi-solid (drops, gels, or ointments) or even a patch type suitable for transdermal
application. Apart from these formulations, which are designed to deliver APIs
without passing the gastro-intestinal tract (GIT), are the oral dosage forms. Oral
dosage forms can be administered either as solutions and suspensions i.e. syrup,
or tablet-like solid forms such as pills, tablets, capsules, and buccals.
Unlike intravenous (IV) medications, delivering oral dosage forms does not
involve invasive application. Therefore, they are of great acceptance by patients
and have been the most popular way for delivering APIs since the nineteenth
century176. Oral solid dosage forms are again the favourable delivery systems from
industrial point of view as they involve less costly techniques and preparations.
In order to prepare such formulations, certain criteria should be considered
regarding the solid-state form of the APIs. Ideally, APIs should provide the
needed solubility, acceptable stability, low hygroscopicity, a good compatibility
with excipients, and ﬁnally low cost and minimum process of synthesis without any
issue with scaling-up. As mentioned previously (intro 3.2, 4.2), such properties
are more likely to be achieved when employing multi-component systems; of which
and along the course of this chapter, co-crystal was selected to be formulated in
tablet forms and screened for the good manufacturing.
Not only choosing the right state form of the API and selecting the suit-
able dosage form are crucial during drug development and manufacturing process,
but also ﬁnding the robust techniques for screening the resulting pharmaceutical
preparations is also important in the pharmaceutical industry73,85,177. One of the
main goals in the industry is to ensure that medications are always provided to
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patients with a good homogeneous drug distribution containing the whole pharma-
ceutical content. Therefore, it is required to ﬁnd a very reliable, non-destructive,
non-invasive, and very rapid analytical tool to validate such standards. Such
needs underlay within the framework of deploying a real-time quality control tool
in manufacturing and production processes or what is so called PAT74.
PAT encourages pharmaceutical companies to design, analyse and control
manufacturing and production processes via in/on-line manner using appropriate
analytical techniques75. Consequently, vibrational spectral analytical tools are
very beneﬁcial to achieve such targets. Vibrational spectrometers such as Raman
has been until now considered as a non-invasive, non-destructive techniques, and
fast monitoring PAT tool178182. Such instrumentation can be beneﬁcial for the
QC and GMPs in the pharmaceutical ﬁelds especially when the analysis is coupled
with the use of statistics131,183185. The use of Raman spectroscopic technique is
not only based on detecting the molecular vibrations which involves stretching and
bending of intermolecular interactions but also it probes the phonon excitations
(intramolecular interactions) and thus it is beneﬁcial to investigate the emerging
phases i.e., polymorphs within pharmaceutical formulations186.
There are several spectroscopic techniques which utilise Raman scattering
radiations, of which two Raman techniques were employed through this research
work; the backscattering (chap 3, 4) and the transmission Raman modes (chap
5). Backscattering mode was shown to be of beneﬁcial for screening co-crystal
preparations and other emerging forms (chap 3, 4). Along the course of this
chapter, Raman transmission spectroscopy will be tested on model co-crystal
tablets. The main diﬀerence between both transmission and backscattering modes
is the way photons travel through samples. Fig 5.1 shows a schematic layout of
both transmission and conventional Raman spectroscopy. In Raman transmission
mode (ﬁg 5.1 a), photons of the electromagnetic radiations diﬀuse through the
sample and pass the entire volume content to be detected in a forward geometry.
Contrary to the transmission Raman spectroscopy, laser light in the conventional
backscattering mode (ﬁg 5.1 b) is scattered from the surface of the sample and
detected in a backward geometry.
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Figure 5.1: Schematic of transmission and backscattering Raman techniques.
It shows the experimental layout of both the transmission vs the conventional
backscattering modes. In transmission mode (a), the electromagnetic light shined
on the sample travels ballistically (penetrates and scatters) through the sample of
a tablet, then detected in forward geometry. Alternatively in (b), the illuminated
laser is scattered from the surface of the sample and detected in a backward
geometry.
Taking a decision about using any mode of Raman spectroscopic tech-
niques is related to the real goals the operator wants to achieve, and the ex-
perimental design which accordingly leads to a speciﬁc data interpretation. For
instance, it is feasible through backscattering Raman technique to run either a
single point, or even parametric measurements in which vibrational signals are
obtained as a function of various factors such as temperature, pressure, and di-
mensions (XY surface mapping, XYZ three-dimensional mapping herein depth is
included)81,117. The three-dimensional screening could be performed in consec-
utive steps; layer by layer (as achieved by backscattering mode), or in one go
leading to a bulk screening (as in transmission Raman spectroscopy)187.
Both Raman modes have proven their well suitability to be employed
in the pharmaceutical ﬁeld. For instance, the backscattering mode is good for
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studying the drug distribution within pharmaceutical solid dosage forms.∗ Nev-
ertheless when choosing to probe the bulk content of pharmaceutical prepara-
tions, Raman backscattering mode is not ideal as it is restricted with diluted
thinner samples. Such bias in surface layer could be overcome by using transmis-
sion Raman spectroscopy which was found to be superior, as it does not probe
layer by layer but rather the entire volume content188,189. Moreover, it has also
been found that the issue of sub-sampling and ﬂuorescence, correlated with the
backscattering spectroscopy, could be avoided when using Raman spectroscopy
in transmission mode84. Hence with a new approach within the vibrational spec-
troscopic schemes, TRS is useful to overcome the disadvantages accompanied the
conventional Raman spectroscopy (backscattering mode) when probing the entire
content of pharmaceutical preparations131.
TRS has been used for characterisating powders of single component con-
tent in their loose form186, or after being concealed in diﬀerent plastic con-
tainers182. TRS has also been employed for screening capsules83,187,188,190 and
tablets84,189,191 of multiple pharmaceutical contents. More importantly, it was
also proven to be suitable for probing multi-component systems (complexes) such
as co-crystals in their powder form183, but it has never been tried when com-
plexes exist in pharmaceutical dosage form (capsules or tablets). Therefore, a
model co-crystal system FBP-NCT, previously studies in chap 3, 491,168, was
selected as a solid-state form of the API to be prepared in tablet dosage form and
later screened by the transmission Raman spectroscopy.
FBP is a part of carboxylated group from the non steroidal anti inﬂamma-
tory drugs (5.2 a) which is used as an analgesic. NCT is a vitamin B3 derivative
(5.2 b), listed as a member of GRAS materials192 and has been used as a co-
crystal former23,91,158. The co-crystallisation between FBP and NCT was facili-
tated by liquid-assisting grinding technique46,159, which resulted in the formation
∗Similar observation was noticed when such technique was employed to study the
FBP-NCT Koﬂer melt preparation (chap 3). The outcomes revealed the spatial distri-
bution of components within the preparation and indicated to the polymorphism issue
in FBP-NCT co-crystal system.
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Figure 5.2: Chemical structures of FBP (a), NCT (b), and their co-crystal (c).
of 1:1, FBP-NCT co-crystal (ﬁg 5.2 c).∗ Realistic formulations of the API (1:1,
FBP-NCT co-crystal) was later performed in tablet forms, containing the API
and some tableting agents/excipients. Excipients compromised all of the follow-
ings; lactose (ﬁlling agent), avicel (a direct compression agent), and Mg Stearate
(lubricant).
According to knowledge, this is the ﬁrst time whereas co-crystals are being
formulated in tablet dosage form. There are few examples in literature discussing
the unintentional emerging of co-crystals between the APIs and excipients, i.e.
the formation of co-crystals upon changes in the storage conditions between car-
bamazepine and nicotinamide in carbamazipine tablets, and between salicylic acid
∗Refer to appx C regarding Raman and XRD characterisation of FBP-NCT co-crystal
formation (ﬁg C.1).
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and nicotinamide in aspirin tablets193. Nevertheless, there was not any example
in literature showing the attempt of formulating co-crystals in solid-dosage form.
Screening FBP-NCT co-crystal tablets was performing in parallel with sets of ref-
erence tablets containing the physical mixtures of both parent components (FBP
and NCT). Tablets were made in two diﬀerent percentage of drug contents (25%
and 50%).
Therefore, the aim was to study two main points. The ﬁrst one is to
investigate whether TRS can distinguish between tablets of identical percentage
of composition but diﬀerent molecular properties i.e., co-crystal vs physical mix-
tures. The second aim is to investigate if TRS can diﬀerentiate between tablets
of identical molecular properties but diﬀerent in the ratios of drug contents i.e.,
co-crystal tablets of 25% ratio vs co-crystal tablets of 50% percentage, similarly is
the case between the 25% and 50% physical mixture tablets. Overall, the layout
of experiments will be of a 2 × 2 matrix; the vertical axis is based on the diﬀer-
ences in chemistry (co-crystal vs physical mixtures) while the horizontal axis is
based on the variation in the ratio of drug contents (25% vs 50%).
5.3 Materials and Methods
5.3.1 Preparation of Tablets
FBP-NCT co-crystals were prepared using liquid assisting grinding technique,
whereas an equimolar mixture of FBP (243.68 mg) and NCT (123.06 mg) was
ball milled for 20 min with a small addition of acetonitrile (30 µL).∗ The resulting
ground powder was then left overnight at RT to allow for any remaining solvent
to evaporate. The full conversion of reagents to co-crystal was conﬁrmed using
Raman spectroscopy and XRPD techniques (ﬁg C.1).
FBP-NCT co-crystal and their equimolar physical mixture were dry com-
pressed into tablets using single punch press ("F3 tablet press", Manesty, Liv-
∗The process was interrupted in between to ensure that the any slurry mixture stuck
on the edges was scraped back into the milling jar.
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Percentage of Ingredients
Tablets Type Tablets no. APIs SDL Avicel PH-102 Mg Stearate
a) co-crystal & phys mix 9 & 9 25% 44% 30% 1%
b) co-crystal & phys mix 6 & 6 50% 30% 19% 1%
Table 5.3.1: Ingredients compositions and their ratios within co-crystal & phys-
ical mixture tablets.
erpool, UK). Tablets were prepared in two diﬀerent percentages of API content;
25% and 50%. The tableting process was assisted using some ﬁlling agents. For
example, the binding between ingredients, and the compaction properties, were
supported by mixing the entire content with spray dried lactose (SDL)194, The
ﬂowability and disintegration were improved by adding microcrystalline cellulose
(avicel PH-102)195, and ﬁnally the adhesion of ingredients during compaction was
reduced by using Mg Stearate (lubricant)196. The ratios of these agents varied
according to the percentage of drug contents within tablets (tab 5.3.1).
For the 25% drug loading tablets, [a) co-crystal & phys mix tablets], the
ratio of SDL was 44%, avicel was 30%, and Mg Stearate was 1%. Alternatively,
the ratios for the 50% drug loading tables, [b) co-crystal & phys mix tablets], were
30%, 19%, and 1%, respectively. Afterwards, the entire contents of each tablet,
regardless to the type of tablets or the percentage of API content, were mixed
and fed separately into the hopper∗, then dry compressed†. The resulting tablets
afterwards were received into vials.
5.3.2 Tablets Screening by TRS
The co-crystal and the physical mixture tablets of 25% and 50% drug content,
and their constituent ingredients were then screened using transmission Raman
spectrometer TRS100 system (Cobalt Light Systems, Oxfordshire, UK). Tablets
were arranged directly in a sample loading tray while the powder ingredients
∗To ensure that an even proportion of ingredients exist in all tablets
†Wet granulation was avoided to ensure the stability of co-crystal and their physical
mixture during formulation process. The presence of the solvent might cause the collapse
of co-crystal into its parent components in co-crystal tablets, or even vice versa forming
co-crystals from the starting components in physical mixture tablets.
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(co-crystal, FBP, NCT, SDL, avicel, Mg Stearate) were placed ﬁrst in a quartz
pan from which spectra were collected automatically. Tablets samples were illu-
minated using transmission Raman laser at a wavelength of 830 nm of a 6 mm
beam diameter and a laser power of 1 W. Laser power and exposure times varied
between referencing powder ingredients. The power was reduced for APIs con-
stituents to be in a range of 0.2  0.75 W with an exposure time of 0.1 s for 20
accumulations, whereas laser power was 1.5 W for excipients for longer exposure
times 1  4 s. The transmitted signal was ﬁltered after being collected slightly oﬀ
the axis to cut-oﬀ the Rayleigh scattering rays. The remaining Raman scattered
signal passed to the spectrometer through ﬁbre bundle. The diﬀracted signal then
was detected by the CCD detector which was cooled to -75 °C to minimise the
noise added to the spectra because of dark current generation.
Generated data were analysed in a separate free package designed by the R
foundation for statistical computing, R version 2.15.0. Data were analysed using
two statistical methods; principal component analysis and hierarchical agglomer-
ative clustering. Few preprocessing steps were performed prior to the analysis;
scaling and mean-centring.∗ Spectral data were arranged in a matrix of two di-
mensions x and y; x column vector represents intensity of each spectrum and y row
is a number of total spectra (1024 × 36). Scaling was achieved by dividing each
column (numerical vector x) by its standard deviation and then mean-centred by
subtracting values in x by its corresponding mean.†
5.4 Results and Discussion
5.4.1 Visual Analysis of Data
Tablets of FBP-NCT co-crystals and their physical mixture, at ratios of 25%
and 50% drug contents each, were subjected to TRS. Equally were the starting
∗Scaling was applied for the ease of visual comparison. It was also applied along with
mean-centring prior to PCA and HAC.
†The eﬀect of baseline subtraction was investigated and provided in the appendix C.
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ingredients; FBP, NCT, co-crystal, lactose, Mg Stearate, and avicel. The 30
Raman spectra of 9 tablets of 25% co-crystal + 9 tablets of 25% physical mixture
+ 6 tablets of 50% co-crystal + 6 tablets of 50% physical mixture, are compared
to 6 Raman spectra of the starting ingredients (ﬁg 5.3). The resulting 36 spectra
are plotted in two spectral regions; phonon region (ﬁg 5.3 a) and molecular region
(ﬁg 5.3 b), stacked in a bottom-top manner in the following order; co-crystal
tablets 25%→ physical mixture tablets 25%→ co-crystal tablets 50%→ physical
mixture tablets 50% → FBP → NCT → co-crystal → lactose → Mg Stearate →
avicel.
From an instant inspection and by looking only at the spectral datasets
of tablets, ﬁg 5.3 revealed a similarity between spectra of each dataset, i.e. all
nine spectra of co-crystal tablets of 25% drug content are identical. Similarly
was the case for spectra from other type of tablets; 25% the physical mixture
tablets, spectra of the 50% co-crystal tablets, and those related to the 50% physical
mixture tablets. This observation indicates to a good reproducibility in spectral
dataset collection.
Hence ﬁg 5.3, shows the suitability of choosing one spectrum from each
type of tablets to represent the entire datasets. Therefore, singular spectra col-
lected from prepared tablets; co-crystal tables in both percentage of drug contents
(25% and 50%) and physical mixture tables in the same drug ratios, are presented
in ﬁg 5.4 a. Again selected spectra are displayed in two spectral regions; phonon
and molecular regions. Further examination in ﬁg 5.4 a, revealed alikeness be-
tween dataset of co-crystal tablets of diﬀerent percentage of drug contents (25%
and 50%), likewise the situation for datasets of physical mixture tablets at simi-
lar ratios (ﬁg 5.4 a). Thereby from a visual examination (ﬁgs 5.3, 5.4 a), the
main distinction factor between datasets of diﬀerent types of tablets appeared to
be based on diﬀerences in chemistry.
Previously selected spectra, which represents dataset of each type of tablets,
(ﬁg 5.4 a) were moreover compared with the spectra collected from tablets' in-
gredients; avicel→ Mg Stearate→ lactose→ co-crystal→ NCT→ FBP (ﬁg 5.4
b). This comparison showed a good compatibility between all spectral datasets of
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Figure 5.3: Experimental design of TRS data. It shows collected Raman spectra
(intensity scaled & oﬀset) of FBP:NCT co-crystal and their equimolar physical
mixture tablets with two diﬀerent percentage of drug contents 25% and 50%.
It shows as well spectra of referencing materials. All data are displayed in two
spectral regions; phonon (a) and molecular wavenumber region (b). Data are
arranged in a bottom-top manner from tablets of lower percentage of drug 25%
towards tablets of higher drug content of 50% whereas spectra of co-crystal tablets
appear ﬁrst followed by data of physical mixture tablets. Stacking on the top of
such spectra are FBP, NCT, co-crystal, lactose, Mg Stearate, and avicel Raman
spectra. Thus, the layout of data becomes as the following; co-crystal 25% (nine
spectra) → physical mixture 25% (nine spectra) → co-crystal 50% (six spectra)
→ physical mixture 50% (six spectra) → FBP → NCT → co-crystal → lactose
→ Mg Stearate → avicel.
tablets (ﬁg 5.4 a) and mainly APIs ingredients (FBP, NCT, co-crystal) but less
obviously excipients (lactose, Mg Stearate, avicel) (ﬁg 5.4 b). Among all APIs
ingredients, co-crystal (ﬁg 5.4 b, green) seemed to be the most dominating fea-
ture in the spectra of (25% and 50%) co-crystal tablets (ﬁg 5.4 a). Alternatively,
both FBP and NCT spectra (phonon region), colour coded respectively in blue &
red (ﬁg 5.4 b), showed some shared information with (25% and 50%) physical
mixture tablets only (ﬁg 5.4 a, box).
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Figure 5.4: Visual inspection of Raman spectral data. It shows in (a) singular
spectra collected from prepared tablets; physical mixture and co-crystal tables
in their both percentage of drug contents (25% and 50%). These data are dis-
played in comparison with referencing spectra (b) in a top-bottom arrangement
starting with physical mixture 50% (one spectrum)→ physical mixture 25% (one
spectrum) → co-crystal 50% (one spectrum) → co-crystal 25% (one spectrum)
→ avicel → Mg Stearate → lactose → co-crystal → NCT → FBP. Again all
data (scaled & oﬀset) are displayed in two spectral regions phonon and molecu-
lar wavenumber region within which the content of tablets showed some shared
chemical features with references as indicated by boxes and segments of lines.
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Figure 5.5: Chemical structure of FBP-NCT co-crystal as calculated from SXD.
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Contrary to observation within phonon region, the spectra of physical
mixture and co-crystal tablets showed comparable similarity with the spectra of
all APIs parent ingredients in molecular region. For instance, shared information
is quite obvious in two narrowed regions; 900  1200 cm-1 and 1600  1700 cm-1
as indicated by boxes in (ﬁg 5.4 a) and segments in (ﬁg 5.4 b).
Raman vibrational frequencies within a range of 900  1200 cm-1 is thought
to be related to the rocking of nicotinamide NH2 group, and to the out-plane de-
formation of ﬂurbiprofen carbonyle group γ(OCOCH3 ) and FBP ω(CC)rings
wagging23,197. Equally, the chemical features at 1600  1700 cm-1 correspond to
nicotinamide ν(C=O) stretching, and to the symmetric vibrational stretching of
ﬂurbiprofen aromatic rings νs(CC)rings 23,197. Sharing such information is quite
meaningful because it refers intuitively to FBP and NCT functional groups (ﬁg
5.5). FBP and NCT complementary groups could serve as potential sites for both
FBP and NCT molecular interaction. Therefore, the existence of these features
in the datasets of tablets indicates to the presence of both FBP and NCT either
in a physical mixture form or co-crystal form; requirements aimed to be achieved
when preparing tablets.
5.4.2 Chemometric Analyses
As was alluded earlier from the visual inspection (ﬁg 5.3), the diﬀerentiation
between components was merely based on the molecular properties of pharmaceu-
tical ingredients (chemistry). Nevertheless, the visual inspection could be subjec-
tive and not quite deﬁnitive, i.e. the comparability of information between com-
ponents of diﬀerent chemistry (physical mixture vs co-crystal tablets) in some
speciﬁc wavenumber regions; regions of molecular interactions 900  1200 cm-1
and 1600  1700 cm-1 (ﬁg 5.4). In addition, there was not any new information
provided, regarding identical materials of diﬀerent ratios (25% physical mixture
vs 50% physical mixture, and 25% co-crystal tablets vs 50% co-crystal tablets)
(ﬁg 5.4).
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Figure 5.6: Analytical design of co-crystal & physical mixture tablets data.
Data of FBP:NCT co-crystal and physical mixture tablets in two diﬀerent drug
contents 25% and 50% are arranged in four panels (a → d). Raman spectra are
classiﬁed according to their drug ratios (25% (a, c) → 50% (b, d); left → right),
and in relation to their chemical content (co-crystal (a, b)→ physical mixture (c,
d); top → bottom).
Hence, the visual analysis was performed in parallel with unsupervised
chemometric methods (PCA & HCA). The spectral datasets of tablets were re-
arranged (ﬁg 5.6), before subjecting data to PCA & HCA, prospecting that
analysing TRS data with chemometrics might yield interesting outcomes related
to the distinction between tablets according to their materials properties (chem-
istry) and the percentage of drug contents (molecular composition). Fig 5.6
classiﬁes co-crystal and physical mixture tablets of 25% and 50% drug percent-
ages in four panels (a → d). The eﬀect of drug loading is displayed horizontally
(25% vs 50%), while the chemical content eﬀect is shown vertically (co-crystal vs
physical mixture).
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Principal Component Analysis:
PCA was used to re-map TRS data, with a minimum interference by operator, into
lower spatial dimensions so data becomes simpler to interpret121. PCA was ap-
plied on variance-scaled and mean-centred data. Only four PCs, covering 97.87%
of data variation, were believed to provide suﬃcient information for the study (ﬁg
C.2). Consequently, the rest of PCs were not included as they were considered
less informative.∗ †
The ﬁrst two PCs were selected for visualising data in 2D subspace of the
PCA reduced dimensionality space, whereas the scores of both PCs were plotted
against each other, as shown in the scatter plot (ﬁg 5.7). A lot of information
could be alluded from the scatter plot especially when choosing two PCs of widely
diﬀerent variations, such as PC1 (66.90%) vs PC2 (14.25%). Plotting the scores
of such PCs is beneﬁcial in revealing the aﬃliation of clusters. It is also important
to make the distribution of less variable datasets more distinguishable, i.e. reveal-
ing more spread out of nearby small clusters. Herein, points within the scatter
plot (ﬁg 5.7) refer to the spectral datasets acquired from tablets and referenc-
ing ingredients. Therefore, ﬁg 5.7 shows the distribution of PC1 scores against
the spread of PC2 scores for similar datasets. Points correspond to 36 spectral
datasets; co-crystal 25% (9 points, empty diamond), co-crystal 50% (6 points,
crossed diamond), physical mixture 25% (9 points, (X) square), physical mixture
50% (6 points, crossed square), FBP (one point, blue square), NCT (one point,
red triangle), co-crystal spectrum (one point, green plus), lactose (one point, ma-
roon asterisk), Mg Stearate (one point, grey cross), and avicel (one point, crossed
circle).
Now by looking at the scatter plot (ﬁg 5.7), the ﬁrst eye catching obser-
vation is the presence of four distinct clusters, which are related to the following
∗Fig C.2 shows a clear cut-oﬀ in PCs variations at PC6 after which the changes in
PC variations become very steady.
†More information about the loading of PCs are listed in the appx C. The loadings of
PC4 & PC5 revealed repetitive information to those exist in the ﬁrst four PCs, therefore
only the ﬁrst four PCs were believed to be suﬃcient.
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datasets; the physical mixture tablets of 25%, and 50% drug contents, another
two sets linked to their co-crystal tablets of similar ratios (25%, and 50%). The
scores of four datasets are almost located in diﬀerent quadrants of the scatter
plot (ﬁg 5.7) which also displays a separate distribution of other six points, re-
ferring to the ingredients of tablets (excipients and APIs). Data points which
correlate with excipients (lactose, Mg Stearate and avicel), distribute apart from
those correspond to APIs (FBP, NCT, and co-crystal).
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Figure 5.7: Scatter plot of principal components 1 vs 2. The plot shows the
scatter of PC2 (14.25%) scores against those of PC1 (66.90%). The diﬀerences in
chemistry (drug contents) appears to be clearer on PC2. On the other hand, PC1
reveals the variation in tablets with diﬀerent ratio of contents (25% and 50%).
Shapes and colour codes: black squares and diamond=tablets data, dark grey
cross=Mg Stearate reference spectrum, blue ﬁlled square=FBP reference spec-
trum, red ﬁlled triangle=NCT reference spectrum, dark green plus=co-crystal ref-
erence spectrum, maroon asterisk=lactose reference spectrum, and brown crossed
circle=avicel reference spectrum.
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Detailed observations were revealed when examining, in a counterclockwise man-
ner, the four quadrants of the scatter plot (ﬁg 5.7);
 The ﬁrst quadrant encompasses the physical mixture tablets of 25% drug
loading. Therefore, 25% physical mixture tablets are expected to have
positive loadings on both PC1 and PC2.
 The second quadrant accommodate the 50% physical mixture tablets plus
FBP reference. Consequently, both of the 50% physical mixture tablets and
FBP reference are negatively loaded on PC1 while positively projected on
PC2.
 Thus, the ﬁrst and second quadrants compromise physical mixture tablets
of both 25% and 50% ratios. More speciﬁcally, the 25% (+ on PC1), and the
50% (− on PC1) physical mixture tablets appeared to be well distributed
along PC1 axis but not on PC2.
 The third quadrant contains the 50% co-crystal tablets along with the ref-
erences of NCT and co-crystal, so this means all of them are negatively
loaded on both PC1 and PC2.
 The fourth quadrant includes most of the 25% co-crystal tablets∗† so for
most of the 25% co-crystal tablets, data are positively projected on PC1
but negatively loaded on PC2.
 Thus, the third and fourth quadrants enclosed co-crystal tablets of both
25% and 50% ratios. The 25% (+ on PC1) and the 50% (− on PC1) co-
crystal tablets seemed as well to be spread out along PC1 axis but not on
PC2.
∗Out of 9 spectra of the 25% co-crystal tablets, only the ﬁrst spectrum is located
slightly further from the rest of the dataset. The 25% co-crystal tablet no.1, is in between
the clusters of both the 25% and 50% co-crystal tablets; indicated to by an arrow in ﬁg
5.7.
†Refer to appx C for further details about the spectra of the 25% co-crystal tablets.
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 The ﬁrst and second quadrants contains physical mixture tablets of both
25% and 50% ratios, while the third and fourth quadrants encompasses co-
crystal tablets of similar ratios. Thereby, physical mixture and co-crystal
tablets appeared to be well separated along PC2 but not PC1.
 As for the excipients, all of lactose, avicel, and Mg Stearate appeared to
have noticeable positive loadings on PC1 compared to PC2. Excipients'
projections on PC2 are very minimum. More speciﬁcally, the loadings of
lactose and avicel are slightly negative while those of Mg Stearate is to some
extent positive on PC2. More importantly, nevertheless, is the location of
excipients. Lactose, avicel, and Mg Stearate are localised nearby tablets
of lower drug content. They are between the clusters of both the 25%
co-crystal and the 25% physical mixture tablets.
 Alternatively, API references (FBP, NCT, and co-crystal) are positioned
nearby tablets of a higher drug content 50% (second and third quadrants).
For instance, FBP is localised in the same quadrant (second) of the 50%
mixture tablets, while NCT and co-crystal are in the third quadrant close
to the 50% co-crystal tablets.
To further support previous assumptions about dataset distribution, more inspec-
tion was performed on PC loadings. The ﬁrst and second PCs were checked out
for any related chemical information.∗ The investigation of PCs loadings was
performed in comparison with reference Raman spectra of tablets' ingredients; in
both phonon (40400 cm-1) and higher wavenumber regions (4001800 cm-1) (ﬁg
5.8), and within a range of 40-600 cm-1 (ﬁg 5.9).
The reference spectra of tablets' ingredients (FBP, NCT, lactose, Mg
Stearate, and avicel) exhibited some positive and negative projections on PC1,
such similarity is indicated to by boxes (ﬁg 5.8). Spectra of negative loadings are
arranged below PC1 while the one of positive loadings is above. Therefore, the
layout of the spectra and loading becomes as following; bottom→ top: NCT (red,
∗Refer to appx C for further information related to the loadings of PCs (ﬁgs C.3,
C.4, C.5, C.6, C.7, C.8).
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Figure 5.8: PC1 loadings in comparison with referencing Raman spectra of
tablets' ingredients. Spectra and PC1 loading are arranged in a bottom-top man-
ner; NCT (red), co-crystal (green), FBP (blue), PC1 (black), lactose (maroon).
Below PC1 are spectra of negative drug loadings (NCT, co-crystal, and FBP)
while the one above PC1 is of positive drug loadings (lactose). Spectra of tablets'
ingredients were scaled by 1/20 for sake of clear presentation.
−), co-crystal (green, −), FBP (blue, −), PC1 loadings (black), lactose (maroon,
+) (ﬁg 5.8). Thus, PCA statistical outcomes appeared to contain meaningful
chemical information as supported by PC1 loadings. This ties nicely with the
scatter plot ﬁg 5.7 whereas all APIs ingredients; FBP (2nd quadrant), NCT and
co-crystal (3rd quadrant) are negatively projected on PC1 axis.
As for PC2, only FBP spectrum was found to exhibit some positive load-
ings on PC2 within the wavenumber range of 40600 cm-1 (ﬁg 5.9, boxes).
Hence, the spectrum of FBP (blue, +) was arranged above PC2 loadings (black)
(ﬁg 5.9). Again such observation correlates well with the positive projection of
FBP (2nd quadrant) on PC2 axis (ﬁg 5.7).
Overall, interesting ﬁndings were discovered by looking into some of PC
loadings and the clusters of all datasets (ﬁgs 5.7, 5.8, 5.9); tablets of physical
mixture 25%, physical mixture 50%, co-crystal 25%, co-crystal 50%, APIs, and
excipients. Firstly, more information were deduced in regards to the ingredients
of tablets (APIs and excipients), more speciﬁcally the sensible nearby localisation
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Figure 5.9: PC2 loadings in comparison with reference Spectra Raman spectra of
FBP. The spectrum of FBP (blue) which has positive loadings on PC2 is arranged
above PC2 loading (black). FBP spectrum was scaled by 1/20 for presentational
purpose.
of components with comparable volume content. For instance, APIs localise close
to tablets of higher drug content (50%) leaving excipients among tablets of lower
drug content (25%). Secondly, the ready separation between tablets of diﬀerent
drug loading (25% and 50%) was noticed from data projections along the axis of
PC with a higher variation (PC1, 62.82%). In another word, co-crystal tablets
of 25% and 50% drug contents are well apart base on their projection on PC1.
Similarly was the case of physical mixture tablets of 25% and 50% drug contents.
Thereby, PC1 can be called herein the axis of composition (ﬁg 5.7). Alternatively,
the diﬀerentiation according to chemistry was clearer on the axis of PC with a
lower variation (PC2, 14.25%), i.e. tablets of various drug contents (co-crystal
vs physical mixture tablets) are separated along PC2 (14.25%) rather than along
PC1 (62.82%). Thus, PCs can be called herein the axis of chemistry (ﬁg 5.7).
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Hierarchical Agglomerative Clustering:
Earlier interesting conclusion about data distribution, drawn from the scatter
plot (ﬁg 5.7) and the study of PCA loadings (ﬁgs 5.8, 5.9), were carefully
examined and clariﬁed by means of cluster analysis (HAC analysis in speciﬁc).
The distribution of datasets is aﬀected by the degree of similarity and dissimilarity
which could be calculated in various ways, however the most related method to
PCA for measuring data similarity is Euclidean method121. Therefore, Euclidean
method was the method of choice herein to work out the distance between similar
pairs which later were linked in a bottom-top manner using Ward's agglomeration
method HAC.
HAC analysis was performed on intensity scaled data (5.10).∗ Data com-
promise 36 sets related to tablets of all drug contents (30 spectra)†, and tablets'
individual ingredients (6 spectra)‡. Moreover, HAC analysis was performed in
three wavenumber regions; the entire Raman region (ﬁgs 5.10 a), phonon re-
gion < 400 cm-1 (ﬁgs 5.10 b), and higher molecular region > 400 cm-1 (ﬁgs
5.10 c). The resulting linked data of the HAC analysis, performed in the three
wavenumber regions, were framed in boxes respectively coloured in green, red,
and blue. Now by looking at the HAC outcomes (ﬁg 5.10), when analysis was
performed on intensity scaled data only without baseline correction preprocessing,
some interesting observations are noticed;
1. The ﬁrst dendrogram (ﬁg 5.10 a, green), which refers to HAC analysis
within the entire wavenumber region, displayed the followings;
 The ﬁrst level of clustering interestingly revealed the loading-based
distinction between datasets. In another word, the main two branches
∗ The eﬀect of baseline correction on such analysis is presented in appx C (ﬁgs C.9,
C.10, C.11, 5.11, C.12, C.13, C.14, C.15, C.16).
†30 tablets spectra: 25% co-crystal loading (9 spectra), 25% physical mixture loading
(9 spectra), 50% co-crystal loading (6 spectra), and 50% physical mixture loading (6
spectra).
‡6 references spectra: FBP, NCT and their co-crystal, lactose, Mg Stearate and avicel.
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of the dendrogram captured the 50% drug content tablets against
tablets of the 25% drug ratios. Within tablets of the higher drug
content (50%) categorised API ingredients (FBP, NCT, and their
co-crystal), whereas they were excipients (lactose, avicel, and Mg
Stearate) which localised within tablets of the lower drug content
(25%).
 More speciﬁcally (levels down) in the 50% drug ratio branch, all of
API references (FBP, NCT, and their co-crystal) are classiﬁed within
the same sub-branch of the 50% physical mixture tablets away from
the sub-branch of co-crystal tablets of 50% ratio. From the APIs, only
FBP was directly linked to the 50% physical mixture tablets while the
rest of APIs (NCT and co-crystal) are paired one level above.
 On the 25% drug ratio branch (levels down), excipients were linked
together in a separate sub-branch from the one which holds both of
co-crystal and physical mixture tablet sets of the 25% drug ratio. The
latter by its turn sub-classiﬁed into two categories; co-crystal tablets
of 25% ratio and physical mixture tablets of similar percentage.
 Hence, the chemistry based distinction between datasets can be al-
luded by another look at secondary levels of clustering. For instance,
the diﬀerentiation between co-crystal and physical mixture tablets was
mainly noticed one branch below both main branches (drug loading-
based branches).
2. The second dendrogram (ﬁg 5.10 b, red), which refers to HAC analy-
sis within the phonon region, revealed comparable observations to those
deduced from the ﬁrst dendrogram (entire wavenumber region). There are
however some minor changes related to the way the APIs were sub-classiﬁed
with tablets of higher drug percentages (50%), i.e. only FBP was paired
with physical mixture tablets (50%) leaving co-crystal and NCT references
to be linked with co-crystal tablets of similar ratio.
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25% co-crystal tablets exhibited noticeable background (ﬁg C.12 b) which
seemed to aﬀect HAC outcomes (ﬁg 5.10 c, blue). Therefore, HAC analy-
sis performed after subjecting datasets to baseline correction preprocessing,
resulted in a sensible classiﬁcation of the ﬁrst tablet of the 25% co-crystal
loading (ﬁg 5.11).∗
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Figure 5.11: Statistical pre-treatment eﬀects on molecular data, Dendrogram (a)
vs Spectra of 25% co-crystal (b). Data herein are intensity scaled and baseline
subtracted before performing cluster analysis. Tablet number 1 from the 25%
co-crystal content is referred to by red arrow in dendrogram plot (a) while its
spectrum is coloured in red (b). The rest of 25% co-crystal tablets data are in
black (b).
Overall, HAC and PCA showed the main structure of datasets which is
deﬁned by the percentage of drug contents and not by chemistry, contrary to vi-
sual inspection which indicated the chemistry diﬀerences between datasets. Such
outcomes could be justiﬁed based on the tendency of visual inspection to be sub-
jective which leads mostly to incomplete story. HAC outcomes clariﬁed PCA
observations such as revealing the distinction between all datasets regardless to
∗HAC analysis was performed on intensity scaled and baseline corrected data within
the entire Raman region, phonon, and molecular region (ﬁg C.13).
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their composition and contents. Besides to the way the references (tablets' in-
gredients) were categorised which seems to be intuitively sensible. For instance,
APIs classiﬁed with tablets of higher drug contents, contrary to excipients which
tend to cluster with tablets of lower drug content. Hence, the diﬀerentiation be-
tween tablets of diﬀerent content, observed by visual inspection, was supported by
chemometrics. This was in opposite to the distinction between diﬀerent percent-
age of identical drug contents which was not at all alluded from visual examination
(ﬁgs 5.3 & 5.4), until PCA and HAC were employed (ﬁg 5.7, 5.10). Thereby,
the distinctions between tablets' ingredients regardless to their contents and per-
centages were feasible from the parallel usage of both visual and chemometric
analysis.
5.5 Conclusion
Interesting information related to drug development and manufacturing were re-
vealed by using the new approach within vibrational spectroscopic schemes TRS,
in a couple with unsupervised statistical analysis (PCA and HAC). This was
tested for the ﬁrst time on FBP-NCT co-crystal oral dosage form. The study
displayed a clear distinction between components of diﬀerent chemical identities
from the visual inspection which was later clariﬁed by statistical analysis. The
latter analyses (PCA and HAC) also diﬀerentiate between identical components
of various percentage of loadings. Therefore, the use of such analytical tool can
be of a great beneﬁt for the quality control and the good manufacturing processes
in the pharmaceutical ﬁeld.
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Figure 5.12: Conclusion ﬁgure of Screening Model Co-crystal Tablets by TRS.
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CHAPTER 6
General Discussion & Conclusion
The work presented earlier described screening model co-crystal system start-
ing from preparation until formulation using various methodologies and analyt-
ical tools. Based on previous work done by Berry et al.91 and Shing et al.86,
ﬂurbiprofen-nicotinamide co-crystal was selected as a model system for this work.
The co-crystallisation mostly involved friendly environment methodologies such
as Koﬂer fusion method and mechanochemical co-grinding. The resulting mate-
rials from grinding method were formulated in tablet dosage form. The screening
of preparations was mostly performed using rapid and non-destructive analytical
tools.
For instance, the work presented in chap 3 handled the use of Koﬂer
preparations to study binary systems which are generally diﬃcult to prepare using
traditional methods (i.e., evaporation from solution). Koﬂer preparation are tra-
ditionally assessed using the hot-stage microscopy91. One of the main objectives
of this work was to develop a detailed protocol for screening Koﬂer preparations
at room temperature using Raman spectroscopy. Raman spectroscopy yielded
valuable chemical and physical insights into components, and the sensitivity of
screening was strongly enhanced when considering low wavenumber region, which
probes the crystalline structure of components198. In this chapter the new co-
crystal phase and another polymorphic form of FBP were identiﬁed by means of
statistical analysis PCA and DCLS. In addition, a reﬁnement was made regarding
the prediction of binary phase diagram from Koﬂer melt. It was shown that the
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composition gradient is not linear as a function of position as had been tradi-
tionally presumed. Hence, this protocol provided additional information which
might advance the ﬁeld of co-crystal screening. An overall summary for the work
presented in this chapter is displayed in ﬁg 6.1.
A continuing study on FBP-NCT Koﬂer preparation was shown in chap
4. Such system which already consisted of NCT and FBP holding at the in-
terface FBP-NCT co-crystal form I168, was accompanied on prolonged storage
at ambient condition by a co-crystal form II running along the zone of mixing.
The phenomenon of drug polymorphism whether it is single or multi-component
systems is of an impact on the quality of drug production if it is not under-
stood. Thereby, a suﬃcient understanding of the transformation process between
forms was explored. Accordingly, the FBP-NCT co-crystal polymorphism was
investigated. It was found that the preparation of co-crystal sample suitable for
polymorphism study was achievable when adopting Ostwald's rule of step changes
protocol. Henceforth, a quenched equimolar mixture of FBP:NCT was prepared
and investigated using;
 DSC as initial thermal scanning helped in optimising methods of prepa-
ration and this was also conﬁrmed optically when using polarised thermo-
microscopy (HSM).
 VT-Raman accompanied with PCA as a clustering technique provided a
clear identiﬁcation of all FBP-NCT phases; amorphous → co-crystal form
I → the melt of CC I → co-crystal form II → melt.
 Alternatively in VT-XRPD, analysis showed only four phases instead of ﬁve
(amorphous → co-crystal form I → co-crystal form II → melt), despite the
similarity in sample preparation. In another word, solid/solid transforma-
tion was picked up and this was more likely due to some technical issues
(uneven heating atmosphere surrounding the sample), which resulted in the
rearrangement between co-crystal forms.
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 It was also found from VT-XRPD that the transformation led to the stable
form which matched well with the calculated powder pattern based on single
x-ray crystal experiment.
 Regarding the crystal structure determination, the crystal structure of one
form was determined. It was found that the interaction between FBP:NCT
occurs in an equimolar ratio via pyridine-carboxylic acid heterosynthon,
separated by amid-amid dimer.
In summary, the thermal screening (DSC and HSM), Raman spectroscopy, and
diﬀraction methods (XRPD) displayed the presence of a metastable form in FBP-
NCT co-crystal system before forming the stable form 1:1. An overall summary
for this study is presented in ﬁg 6.2.
Finally in chap 5, FBP-NCT co-crystal prepared using LAG method was
formulated in tablets form for the ﬁrst time. It was demonstrated that co-crystal
and not individual API exists within formulation. Moreover and by using analyt-
ical tool sensitive to solid-state substances (transmission Raman spectroscopy), a
distinction was made between formulations containing FBP-NCT co-crystals and
those containing co-crystal parent components. It was also proved that a distinc-
tion based on the ratio of drug composition, not only the chemistry was feasible
using chemometric tools (PCA and cluster analysis). A summary illustrating this
study is shown in ﬁg 6.3.
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Refinement about Kofler Preparation from In-situ Raman Screening
             Few techniques have been employed to generate 
co-crystals, of which is the contact fusion method (Kofler 
melt) - described by Lehmann in 1888 , refined later by 
Kofler and McCrone [1]. The Kofler melt preparation was 
traditionally screened using hot-stage microscope, which 
remained unmodified since McCrone's work. 
In this Chapter, the first application of spectroscopic 
mapping for screening Kofler melt co-crystal preparation is 
reported. 
Confocal Raman microscopy/spectrometry was the 
adopted technique to characterise the molecular and 
crystalline entities [2] in a model Kofler melt flurbiprofen-
nicotinamide (FBP-NCT) system [3] and their spatial 
distribution. 
Nicotinamide (NCT )
-co-former-
-CONH2
N-pyridine
-COOH
Flurbiprofen (FBP) 
-API-
Chapter 3 Motivationt r  ti tiv Results & Discussion
Analysis of Raman Maps
lt   i is s sc ss
Analysis of Ra an apsm M
Experimental Section
Raman Mapping for Kofler Preparation
ri t l tiExpe en a Sec on
Ra an apping for Kofler Preparation
Kofler Fusion Method
Raman Mapping
la
s
e
r
translation of stage
NCTFBP
Co-crystal
IIIII
cooling
raising 
temperature
cooling
Heating the 
higher melting 
component 
(NCT) until 
melting occurs 
melting the
 lower melting 
component (FBP)
waiting for 
crystallisation to 
occur
NCTFBP
NCT
Data Analysis
(PCA)
I
Conclusionl ic sResults & Discussionlt   i is s sc ss
Kofler preparation was confirmed optically and chemically 
before conducting Raman mapping ➢ The work presented outlines the first use of Confocal 
Raman microscopy to characterise Kofler melt preparation.
➢ Valuable detailed information on the investigated phases 
were generated from Raman mapping using chemometric 
approach (PCA).
➢ It shows the presence of the starting components and the 
emerging phases (co-crystal and FBP polymorphism) with and 
their spatial distribution.
[1a] O. Lehmann, Molecularphysik, Engelmann, Leipzig, 1888. [1b] Kofler. L and Kofler. A, Thermalmicromethods for the study of organic compounds and their mixtures, Wagner; translated by 
McCrone, W. C.; McCrone Research Institute: Chicago, 1980., Innsbruck, 1952. [1c] W. C. McCrone, Fusion methods in chemical microscopy, Interscience Publishers , New York, 1957. 
[2] S. Al-Dulaimi, A. Aina and J. Burley, Crystengcomm, 2010, 12, 1038 -1040. 
[3] D. J. Berry, C. C. Seaton, W. Clegg, R. W. Harrington, S. J. Coles, P. N. Horton, M. B. Hursthouse, R. Storey, W. Jones, T. Friscic and N. Blagden, Crystal Growth & Design, 2008, 8, 1697-1712.
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Coupling The Hot-stage With Raman Microscopy Provides New Insight 
Into The Use Of The Kofler Method To Screen Co-crystal Formation
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Figure 6.1: Summary card of research work in chapter 3.
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Conclusionl ic s
on-entional dhermal screenin, Raman ﬃpectroscopy, and 
diffraction methods (XRPD) displayed the presence of a metastable 
form in FBP-NCT co-crystal system before forming the stable form 
1:1. 
Clear identification of all FBP-NCT phases was obtained from 
Raman spectral analysis: (amorphous → co-crystal form I → melt → 
co-crystal form II → melt). 
FBP-NCT 1:1 co-crystal was structurally characterised using 
single x-ray diffraction. Calculated pattern matched well with the 
powder diffraction pattern of co-crystal form II. 
[1]   A. Alkhalil, et. al., “Confocal Raman Microscope Mapping of a Kofler Melt” Cryst. Growth Des., 11 (2011) 422–430.
[2]   A.V. Trask, et. al., “Achieving Polymorphic and Stoichiometric Diversity in Pharmaceutical Cocrystals” Cryst. Growth Des., 5 (2005) 2233-2241. 
Chapter 4: 
1
Optimising  Preparation Methodologists, Coupling Conventional Thermal Screening With The Art-of-State Analytical Tools, And
Choosing Suitable Statistical Analysis, Provide A Platform For Screening Solid-State Pharmaceuticals In The Pre-formulation Stage
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➢ The work presented in chapter 4 was motivated by a notice of 
co-existent forms of co-crystals in FBP-NCT Kofler preparation 
[1]. 
➢ This observation was confirmed from Raman mapping when 
analysed using DCLS. 
Thereby, a sufficient understanding of the transformation process 
between co-crystal forms should be explored using suitable 
analytical tools [2].
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Aalae Alkhalil 128
Chapter 6 General Discussion & Conclusion
Screening Co-crystal in Solid-Dosage Formulation
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Conclusionl ic s
➢   Interesting information related to drug development and 
manufacturing were revealed by using TRS, in a couple with 
unsupervised statistical analysis (PCA and HAC).  
➢ The study displayed a clear distinction between 
components of different chemical identities both visually and 
statistically.
➢ There was also a differentiation between identical 
components of various percentage of loadings proved by  
PCA and HAC.
➢   Therefore, the use of such analytical tool can be of a great 
benefit for the quality control (QC) and the good 
manufacturing processes (GMPs) in the pharmaceutical field. 
Chapter 5: 
The Use Of The Art-of-State Analytical Tools coupled With Suitable Statistical Analysis Is The Gold PAT Option To
Screen Solid-State Pharmaceuticals In Formulations In A Rapid, Non-Invasive, & Non-destructive Manner
The se f The rt-of-State nalytical Tools coupled ith Suitable Statistical nalysis Is The old P T ption ToU O A A A G A O
Screen Solid-State Phar aceuticals In For ulations In  apid, on-Invasive,  on-destructive annerA R N & N M
In this chapter, a  rapid and non-destructive analytical tools were 
explored to study co-crystal in tablets formulation.
Transmission Raman spectroscopy was adopted as an alternative 
option to study molecular complexes over conventional analytical tool as 
the latter can sometimes cause a change in the physical status of 
complexes (i.e., a break in the hydrogen bonds).
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   The first aim in this chapter is to investigate whether TRS can 
distinguish between tablets of different molecular properties, i.e. co-
crystal vs physical mixtures. 
   The second aim is to investigate if TRS can differentiate between 
tablets of identical molecular properties but different in the ratios of drug 
contents, i.e. tablets of 25% vs tablets of 50%.
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Figure 6.3: Summary card of research work in chapter 5.
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Supplementary Info Part-I
Confocal Raman Mapping of Koﬂer Co-crystal System
It can be seen from (ﬁg A.1 a,b) that both sampling points of NCT and FBP
respectively, located in the peripheral regions of the mapped areas, exhibit similar
chemical behaviour to the parent components prepared separately under similar
conditions. Interestingly, this was also the case of the spectrum at the zone of
mixing when compared to the spectra of a melted equimolar mixture of FBP and
NCT (ﬁg A.1 c).
Diﬀerent ratios of FBP and NCT mixtures (1:1, 2:1, and 1:2) were pre-
pared under Koﬂer condition, of which only (1:1) was capable of forming their
co-crystal. Fusing an equimolar FBP:NCT mixture exhibited similar optical (ﬁg
A.2) and chemical features (ﬁg A.1 c) to the one extracted from the zone of
mixing.
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Figure A.1: Raman spectra of NCT, FBP, and co-crystal, from pure samples
and from the Koﬂer melt; (a) is a comparison of separately melted NCT with that
at the NCT side in Koﬂer preparation (right), (b) is a comparison of separately
melted FBP with that at the FBP side in Koﬂer preparation (left), while (c) is a
comparison of an equimolar melted preparation of FBP and NCT with material
at the zone of mixing in Koﬂer preparation (in between).
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50 µm
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FBP:NCT, 1:1 
melted mixture(b)
50 µm
Figure A.2: Morphological similarity between the area of the zone of mixing
in Koﬂer melt (a) and melted equimolar FBP:NCT mixture (b) as conﬁrmed
optically.
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Figure A.3: Scree plots of the ﬁrst three principal components. It shows that
they are assigned > 93% of the whole PCs' variations.
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Figure A.4: RGB colour-map image created by overlapping the ﬁrst three PCs
(being assigned by the anticipated/unexpected compounds and having variances
of > 93%) (ﬁg A.3). This demonstrates the localization of the components in
three regions, which was also noticed form DCLS scores at n=3 (ﬁg 3.5).
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Figure A.5: Raman spectra of Koﬂer components stacked in a top-bottom man-
ner; NCT (black), co-crystal (green), FBP I (red), and FBP II (blue). They are
used as references for the advantage of comparison with PCs loadings (ﬁg 3.9,
bottom images)
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Figure A.6: Comparison of Raman spectra of pure FBP form I and II (red),
and spectra extracted from mapping (black). (a) is a comparison of FBP I with
that extracted from Koﬂer mapping, while (b) is a comparison of FBP II acquired
from single crystal (obtained from solution) with that extracted from FBP area
in Koﬂer mapping.
Aalae Alkhalil 134
Appendix A Confocal Raman Mapping of Koﬂer Co-crystal System
  
angle 2θ /°
In
te
n
s
it
y
 (
o
ff
s
e
t)
calculated pattern of FBP II from CSD
experimental single X-ray pattern of FBP II
Figure A.7: Comparison of X-ray pattern of calculated FBP form II of a ref-
code (FLUBIP01) (red) vs the experimental single x-ray pattern of FBP (black)
obtained spontaneously from acetonitrile solution in attempt to get FBP-NCT
co-crystal form.
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Supplementary Info Part-II
The Study of FBP-NCT Co-crystal Polymorphism
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Figure B.1: Raman microspectroscopic studies of FBP-NCT Koﬂer preparation.
Shown in (a) is Koﬂer preparation after cooling which includes two peripheral
regions, FBP (left) and NCT (right), and the zone of mixing in between, all are
indicated by arrows. In (b) is Raman spectra of NCT (green), co-crystal (blue),
and FBP (red), all are arranged in a top-bottom manner.
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- CONH2
- N pyridine
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2:1, FBP-NCT co-crystal
Figure B.2: Schematic structure of 2:1, FBP-NCT supramolecular synthon. The
interaction is expected to be facilitated via both acid-pyridine and acid-amide
synthons.
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Figure B.3: DSC scanning of co-crystal parent components screened as received.
It shows the thermal traces of NCT at the top (green) and FBP at the bottom
(purple).
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Figure B.4: Modulated DSC of solidiﬁed melted equimolar mixture of FBP-
NCT. It is separated in a top-bottom manner to a non-reverse heat ﬂow trace at
the top (green), the whole heat ﬂow trace in the middle (black), and a reverse heat
ﬂow trace at the bottom (red). The heat ﬂow trace shares with the non-reverse
heat trace similar thermal information. Both display two exothermic events at
47.02 °C and 66.94 °C, and one endothermic event at 95.59 °C. On the other hand,
the reverse heat ﬂow shows two endothermic peaks only.
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Figure B.5: VT-Raman raw data into 2D presentation. A 2D plot of the entire
VT-Raman data of quenched melted 1:1 FBP-NCT mixtures is shown in (a).
Below are 3 sub-plots of VT data at narrower wavenumber regions; (b) phonon
mode, (c) 900 - 1100 cm-1, (d) 1540 - 1660 cm-1. In all these plots, the x-axis
represents Raman shift (cm-1), y-axis is temperature (°C), and colours indicate
to scaled Raman intensity.
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Figure B.6: The Crystallisation of CC I is explained by the variation in the
intensity of CC I spectra. Phonon Raman spectra at a temperature range of 31
→ 74 °C, which correlate with the group of co-crystal form I (ﬁg 4.10 b), are
displayed in (a) with no oﬀset between data. Highlighted in black are spectra at
a temperature range of 31 → 49 °C (bottom sets of spectra), while the ones in
blue were collected over a temperature range of 50 → 74 °C (top sets of spectra).
In (b) is the crystallisation behaviour of CC I, whereas the intensities of phonon
Raman spectra (20 → 200 cm-1) are plotted as a function of temperature range
of 31 → 74 °C.
Aalae Alkhalil 140
Appendix B The Study of FBP-NCT Co-crystal Polymorphism
  Raman Shift (cm-1)
S
c
a
l2
b
 R
a
m
a
n
 I
n
te
n
s
it
y
 
(C
o
u
n
ts
)
NCT
FBP
CC I
CC II
Figure B.7: Raman comparison between co-crystals & the starting components.
Raman spectra extracted at 50 °C (CC I, bottom-middle in red) and 70 °C (CC
II, top-middle in blue) from VT-Raman data of quenched melted 1:1, FBP:NCT,
in comparison with Raman spectra acquired from FBP (top black) and NCT
(bottom black) as received.
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Figure B.8: A comparison between VT-Raman vs VT-XRPD data. VT-Raman
data are shown in (aI & aII) while VT-XRPD are displayed in (bI & bII). Data
are shown into 2D form, whereas y-axis is temperature, x-axis is wavenumber in
(aI) and angle in (b1), and scaled intensities are represented in Z-bar colours.
Both plots (aI & bI) are coupled with a sub plot (left-hand side) of PCs scores
versus temperature, and another one at the bottom for the loading of the ﬁrst two
PCs. In aII & bII respectively, are Raman spectra and XRPD patterns collected
at transition temperatures as alluded from each technique.
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Figure B.9: XRPD comparison between co-crystals & the starting components.
Powder patterns extracted at 47 °C (CC I, bottom-middle in red) and 68 °C (CC
II, top-middle in blue) from VT-XRPD data of quenched melted 1:1, FBP:NCT,
in comparison with powder patterns collected from FBP (top black) and NCT
(bottom black) as received.
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Figure B.10: SXD unit cell of the crystal structure of FBP-NCT co-crystal. It
shows four molecules in each unit cell. The interacting between FBP and NCT
occurred through acid-pyridine hydrogen bonds.
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structure of 1:1 FBP-NCT co-crystals viewed 
along crystallographic (a) direction
Figure B.11: Fragments of the crystal structure of 1:1 FBP-NCT co-crystals
viewed along crystallographic (a) direction. It displays the zigzag shape which is
supported by NCT amid-amide dimer.
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Raman spectrum extracted from VT-Raman experiment of quenched melted 1:1,
FBP:NCT mixture above 77 °C was in a good agreement with the spectrum acquired
from FBP-NCT single co-crystal (ﬁg B.12). Nevertheless, this was not the case of the
spectrum extracted from the compound formed above 31 °C. Thus, keeping the 1:1 melted
FBP-NCT mixture above 77 °C leads to the formation of 1:1 FBP-NCT co-crystal.
Figure B.12: VT-Raman spectra vs spectra of FBP-NCT single crystal. It
shows a comparison between Raman spectra extracted from VT-Raman data at
50 °C (bottom in red) and 77 °C (middle in blue), which correlate with CC I
and CC II respectively, versus Raman spectrum acquired from FBP-NCT single
crystal (top in black).
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Supplementary Info Part-III
QC Probing of Model Co-crystal Tablets by TRS
Characterisation of Co-crystal Prepared by LAG
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Figure C.1: Raman (a) and XRPD (b) characterisation of co-crystal prepared
by LAG (milling with ACN).
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The Variations of Principal Components (screeplot)
The variations of 10 PCs are shown in the chart of ﬁg C.2, and their accumulative
values in the table below ﬁg C.2. It is quite obvious from the table in ﬁg C.2 to
notice that the ﬁrst six PCs covers most of the variations. Fig C.2 shows a clear
cut-oﬀ in PCs variations at PC6 after which the change in the variations becomes
very steady. That is why only six PCs will be included for PCA analysis as the
rest are considered less informative.
  
PC1 PC2 PC3 PC4 PC5 PC6 PC7 PC8 PC9 PC10
Accumulative 
Variations
0.67 0.81 0.92 0.97 0.99 1.00 1.00 1.00 1.00 1.00
Variance % 66.90 14.25 10.64 5.15 2.09 0.72 0.12 0.04 0.03 0.02
Figure C.2: PCA scree plot of tablets data. It shows the variations of ten com-
ponents. The selection of six components is considered as suﬃcient to represent
the whole real data as supported from the bottom table
Further inspection was performed on the ﬁrst 6 PCs' loadings (ﬁgs C.3, C.4,
C.5, C.6, C.7, C.8). A step was needed to check the suitability of including
PCs with meaningful chemical information and excluding ones that bear either
noise or repetitive information.
The loadings of PC1 which accounts for 60.90% of data variance (ﬁg C.3,
top) was plotted in comparison with Raman spectra of tablets' ingredients (ﬁg
C.3, below). The comparison was shown in both phonon (40400 cm-1) and
higher wavenumber region (4001800 cm-1). PC1 loadings showed some resem-
bling features to Raman spectra of tablets' ingredients; in their positive values
with lactose, and negative values with co-crystal (ﬁg C.3). Similar inspection
was done on the loadings of other PCs. PC2 shows shared information with FBP
only (ﬁg C.4), PC3 shared features with NCT and co-crystal (ﬁg C.5), PC4
shares information with lactose and Mg Stearate (ﬁg C.6). PC4 also has got
slight negative background which could be referring to avicel (ﬁg C.6).
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Figure C.3: The loadings of PC1 in comparison with referencing spectra. PC1
loadings is shown in (a) while Raman spectra of references are in (b). Spectra
in (b) are arranged in a bottom-top manner starting from FBP, NCT, co-crystal
(green), lactose (maroon), Mg Stearate, and avicel. Shared information between
PC1 and references are indicated to by signs; green plus and maroon star signs
referred to co-crystal and lactose, respectively.
There are some repetitive information projected on PC5 (ﬁg C.7) and
PC6 (ﬁg C.8). For example, lactose was projected on PC5 (ﬁg C.7) as well as
on PC2 and PC4. Equally was the case for FBP which was projected on both
PC6 (ﬁg C.8) and PC2. Accordingly, only the ﬁrst four PCs are believed to
represent the whole data; both PC5 and PC6 provide redundant information.
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Figure C.4: The loadings of PC2 in comparison with referencing spectra. PC2
loadings is shown in (a) while Raman spectra of references are in (b). Spectra
in (b) are arranged in a bottom-top manner starting from FBP, NCT, co-crystal,
lactose, Mg Stearate, and avicel. PC2 shared some information mainly with FBP
spectrum in the region 40600 cm-1 (ﬁg 5.9).
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Figure C.5: The loadings of PC3 in comparison with referencing spectra. PC3
loadings is shown in (a) while Raman spectra of references are in (b). Spectra
in (b) are arranged in a bottom-top manner starting from FBP, NCT (red), co-
crystal (green), lactose, Mg Stearate, and avicel. Shared information between
PC3 and references are indicated to by signs; green plus and red headarrow signs
referred to co-crystal and NCT, respectively.
Aalae Alkhalil 150
Appendix C QC Probing of Model Co-crystal Tablets by TRS
PC
 L
oa
di
ng
s
0 200 400 600 800 1000 1200 1400 1600 1800
−
0.
2
0.
0
0.
2
Wavenumber (cm−1)
In
te
ns
ity
 (s
ca
led
)
0 200 400 600 800 1000 1200 1400 1600 1800
0
5
10
15
20
(flurbiprofen)
(nicotinamide)
(cocrystal)
(    lactose)
*
(x Mg stearate)
(avicel)
(PC4 loadings)
* * *
* x
x
Figure C.6: The loadings of PC4 in comparison with referencing spectra. PC4
loadings is shown in (a) while Raman spectra of references are in (b). Spectra
in (b) are arranged in a bottom-top manner starting from FBP, NCT, co-crystal,
lactose (maroon), Mg Stearate (X), and avicel. Shared information between PC4
and references are indicated to by signs; maroon star and black X signs referred
to lactose and Mg Stearate, respectively.
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Figure C.7: The loadings of PC5 in comparison with referencing spectra. PC5
loadings is shown in (a) while Raman spectra of references are in (b). Spectra
in (b) are arranged in a bottom-top manner starting from FBP, NCT, co-crystal,
lactose (maroon), Mg Stearate (X), and avicel. Shared information between PC5
and references are indicated to by signs; maroon star and, black (X) signs referred
to lactose and Mg Stearate, respectively.
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Figure C.8: The loadings of PC6 in comparison with referencing spectra. PC6
loadings is shown in (a) while Raman spectra of references are in (b). Spectra
in (b) are arranged in a bottom-top manner starting from FBP (blue), NCT, co-
crystal, and lactose, Mg Stearate, and avicel. Shared information between PC6
and references are indicated to by signs; blue (#) and black (X) signs referred to
FBP and Mg Stearate, respectively.
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The Eﬀect of Baseline Correction on the 25% Co-crystal Tablets Data
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Figure C.9: TRS data comparison: un-treated vs treated. Data are intensity
scaled and oﬀset in (a) adding to such preprocessing, data are baseline subtracted
in (b).
No major changes was observed when the background correction was done
on datasets (ﬁg C.9 a, b). However, it was quite obvious, by looking at the
spectra of the 25% co-crystal tablets (ﬁg C.10), to observe the considerably
high background below all of the spectra. It is also noticeable that 8 of the
spectra are very similar to each other (colour coded in black, ﬁg C.10), apart
from spectrum no.1 (colour coded in red, ﬁg C.10) which was slightly diﬀerent.
This spectrum referred to the ﬁrst 25% co-crystal tablet.∗ Such an observation
justiﬁes the inhomogeneous distribution of 25% co-crystal tablet datasets when
subjected to chemometric (indicated to by an arrow in the scatter plot, ﬁg 5.7).
Consequently, the baseline correction was performed on the spectra of the 25%
co-crystal tablet (ﬁg C.11). Fig C.11 shows an improvement in the degree of
comparability between such spectra.
∗all spectra were normalised to minimise as possible the eﬀect of variable intensities
on chemometric analysis.
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Appendix C QC Probing of Model Co-crystal Tablets by TRS
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Figure C.10: TRS spectra of 25% co-crystal tablets scaled.
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Figure C.11: TRS spectra of 25% co-crystal tablets scaled and baseline sub-
tracted.
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